<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38270460</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1470-8728</ISSN><JournalIssue CitedMedium="Internet"><Volume>481</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>The Biochemical journal</Title><ISOAbbreviation>Biochem J</ISOAbbreviation></Journal><ArticleTitle>The mTORC2 signaling network: targets and cross-talks.</ArticleTitle><Pagination><StartPage>45</StartPage><EndPage>91</EndPage><MedlinePgn>45-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/BCJ20220325</ELocationID><Abstract><AbstractText>The mechanistic target of rapamycin, mTOR, controls cell metabolism in response to growth signals and stress stimuli. The cellular functions of mTOR are mediated by two distinct protein complexes, mTOR complex 1 (mTORC1) and mTORC2. Rapamycin and its analogs are currently used in the clinic to treat a variety of diseases and have been instrumental in delineating the functions of its direct target, mTORC1. Despite the lack of a specific mTORC2 inhibitor, genetic studies that disrupt mTORC2 expression unravel the functions of this more elusive mTOR complex. Like mTORC1 which responds to growth signals, mTORC2 is also activated by anabolic signals but is additionally triggered by stress. mTORC2 mediates signals from growth factor receptors and G-protein coupled receptors. How stress conditions such as nutrient limitation modulate mTORC2 activation to allow metabolic reprogramming and ensure cell survival remains poorly understood. A variety of downstream effectors of mTORC2 have been identified but the most well-characterized mTORC2 substrates include Akt, PKC, and SGK, which are members of the AGC protein kinase family. Here, we review how mTORC2 is regulated by cellular stimuli including how compartmentalization and modulation of complex components affect mTORC2 signaling. We elaborate on how phosphorylation of its substrates, particularly the AGC kinases, mediates its diverse functions in growth, proliferation, survival, and differentiation. We discuss other signaling and metabolic components that cross-talk with mTORC2 and the cellular output of these signals. Lastly, we consider how to more effectively target the mTORC2 pathway to treat diseases that have deregulated mTOR signaling.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ragupathi</LastName><ForeName>Aparna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacinto</LastName><ForeName>Estela</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7118-1759</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM137493</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem J</MedlineTA><NlmUniqueID>2984726R</NlmUniqueID><ISSNLinking>0264-6021</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000076225">Mechanistic Target of Rapamycin Complex 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber><NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="Y">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076225" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Akt</Keyword><Keyword MajorTopicYN="N">SIN1</Keyword><Keyword MajorTopicYN="N">cell growth</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword><Keyword MajorTopicYN="N">mTORC2</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">rictor</Keyword></KeywordList><CoiStatement>The authors declare that there are no competing interests associated with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38270460</ArticleId><ArticleId IdType="pmc">PMC10903481</ArticleId><ArticleId IdType="doi">10.1042/BCJ20220325</ArticleId><ArticleId IdType="pii">233987</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Helliwell, S.B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R. and Hall, M.N. (1994) TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 5, 105&#x2013;118 10.1091/mbc.5.1.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.5.1.105</ArticleId><ArticleId IdType="pmc">PMC301013</ArticleId><ArticleId IdType="pubmed">8186460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cafferkey, R., McLaughlin, M.M., Young, P.R., Johnson, R.K. and Livi, G.P. (1994) Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene 141, 133&#x2013;136 10.1016/0378-1119(94)90141-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-1119(94)90141-4</ArticleId><ArticleId IdType="pubmed">8163165</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitman, J., Movva, N.R. and Hall, M.N. (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905&#x2013;909 10.1126/science.1715094</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1715094</ArticleId><ArticleId IdType="pubmed">1715094</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S.et al. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756&#x2013;758 10.1038/369756a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/369756a0</ArticleId><ArticleId IdType="pubmed">8008069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. and Snyder, S.H. (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35&#x2013;43 10.1016/0092-8674(94)90570-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90570-3</ArticleId><ArticleId IdType="pubmed">7518356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabers, C.J., Martin, M.M., Brunn, G.J., Williams, J.M., Dumont, F.J., Wiederrecht, G.et al. (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270, 815&#x2013;822 10.1074/jbc.270.2.815</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.2.815</ArticleId><ArticleId IdType="pubmed">7822316</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J., Kim, S.G. and Blenis, J. (2014) Rapamycin: one drug, many effects. Cell Metab. 19, 373&#x2013;379 10.1016/j.cmet.2014.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC3972801</ArticleId><ArticleId IdType="pubmed">24508508</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin, D., Colombi, M., Moroni, C. and Hall, M.N. (2011) Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat. Rev. Drug Discov. 10, 868&#x2013;880 10.1038/nrd3531</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3531</ArticleId><ArticleId IdType="pubmed">22037041</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaway, C., Kim, E. and Jacinto, E. (2019) Targeting mTOR and metabolism in cancer: lessons and innovations. Cells 8, 1584 10.3390/cells8121584</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121584</ArticleId><ArticleId IdType="pmc">PMC6952948</ArticleId><ArticleId IdType="pubmed">31817676</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, A., Kunz, J. and Hall, M.N. (1996) TOR2 is required for organization of the actin cytoskeleton in yeast. Proc. Natl Acad. Sci. U.S.A. 93, 13780&#x2013;13785 10.1073/pnas.93.24.13780</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.24.13780</ArticleId><ArticleId IdType="pmc">PMC19424</ArticleId><ArticleId IdType="pubmed">8943012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, X.F., Florentino, D., Chen, J., Crabtree, G.R. and Schreiber, S.L. (1995) TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82, 121&#x2013;130 10.1016/0092-8674(95)90058-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90058-6</ArticleId><ArticleId IdType="pubmed">7606777</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, A., Bickle, M., Beck, T. and Hall, M.N. (1997) The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 88, 531&#x2013;542 10.1016/S0092-8674(00)81893-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81893-0</ArticleId><ArticleId IdType="pubmed">9038344</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D.et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457&#x2013;468 10.1016/S1097-2765(02)00636-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00636-6</ArticleId><ArticleId IdType="pubmed">12408816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H.et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163&#x2013;175 10.1016/S0092-8674(02)00808-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00808-5</ArticleId><ArticleId IdType="pubmed">12150925</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S.et al. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177&#x2013;189 10.1016/S0092-8674(02)00833-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00833-4</ArticleId><ArticleId IdType="pubmed">12150926</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A.et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122&#x2013;1128 10.1038/ncb1183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1183</ArticleId><ArticleId IdType="pubmed">15467718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H.et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296&#x2013;1302 10.1016/j.cub.2004.06.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2004.06.054</ArticleId><ArticleId IdType="pubmed">15268862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y.et al. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125&#x2013;137 10.1016/j.cell.2006.08.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.08.033</ArticleId><ArticleId IdType="pubmed">16962653</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Q., Inoki, K., Ikenoue, T. and Guan, K.L. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820&#x2013;2832 10.1101/gad.1461206</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1461206</ArticleId><ArticleId IdType="pmc">PMC1619946</ArticleId><ArticleId IdType="pubmed">17043309</ArticleId></ArticleIdList></Reference><Reference><Citation>Frias, M.A., Thoreen, C.C., Jaffe, J.D., Schroder, W., Sculley, T., Carr, S.A.et al. (2006) Msin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865&#x2013;1870 10.1016/j.cub.2006.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.08.001</ArticleId><ArticleId IdType="pubmed">16919458</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuttfeld, E., Aylett, C.H., Imseng, S., Boehringer, D., Scaiola, A., Sauer, E.et al. (2018) Architecture of the human mTORC2 core complex. eLife 7, e33101 10.7554/eLife.33101</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.33101</ArticleId><ArticleId IdType="pmc">PMC5837792</ArticleId><ArticleId IdType="pubmed">29424687</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppasamy, M., Kusmider, B., Oliveira, T.M., Gaubitz, C., Prouteau, M., Loewith, R.et al. (2017) Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2. Nat. Commun. 8, 1729 10.1038/s41467-017-01862-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01862-0</ArticleId><ArticleId IdType="pmc">PMC5700991</ArticleId><ArticleId IdType="pubmed">29170376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X., Liu, M., Tian, Y., Li, J., Qi, Y., Zhao, D.et al. (2018) Cryo-EM structure of human mTOR complex 2. Cell Res. 28, 518&#x2013;528 10.1038/s41422-018-0029-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0029-3</ArticleId><ArticleId IdType="pmc">PMC5951902</ArticleId><ArticleId IdType="pubmed">29567957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F.et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159&#x2013;168 10.1016/j.molcel.2006.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.03.029</ArticleId><ArticleId IdType="pubmed">16603397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiota, C., Woo, J.T., Lindner, J., Shelton, K.D. and Magnuson, M.A. (2006) Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11, 583&#x2013;589 10.1016/j.devcel.2006.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.08.013</ArticleId><ArticleId IdType="pubmed">16962829</ArticleId></ArticleIdList></Reference><Reference><Citation>Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J.et al. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC&#x3b1;, but not S6K1. Dev. Cell 11, 859&#x2013;871 10.1016/j.devcel.2006.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.10.007</ArticleId><ArticleId IdType="pubmed">17141160</ArticleId></ArticleIdList></Reference><Reference><Citation>Baretic, D., Berndt, A., Ohashi, Y., Johnson, C.M. and Williams, R.L. (2016) Tor forms a dimer through an N-terminal helical solenoid with a complex topology. Nat. Commun. 7, 11016 10.1038/ncomms11016</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11016</ArticleId><ArticleId IdType="pmc">PMC4833857</ArticleId><ArticleId IdType="pubmed">27072897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wullschleger, S., Loewith, R., Oppliger, W. and Hall, M.N. (2005) Molecular organization of target of rapamycin complex 2. J. Biol. Chem. 280, 30697&#x2013;704 10.1074/jbc.M505553200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505553200</ArticleId><ArticleId IdType="pubmed">16002396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, J., Zhang, D., Kim, K., Zhao, Y., Zhao, Y. and Su, B. (2005) Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation. Mol. Cell. Biol. 25, 5955&#x2013;5964 10.1128/MCB.25.14.5955-5964.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.14.5955-5964.2005</ArticleId><ArticleId IdType="pmc">PMC1168836</ArticleId><ArticleId IdType="pubmed">15988011</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaiola, A., Mangia, F., Imseng, S., Boehringer, D., Berneiser, K., Shimobayashi, M.et al. (2020) The 3.2-&#xc5; resolution structure of human mTORC2. Sci. Adv. 6, eabc1251 10.1126/sciadv.abc1251</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc1251</ArticleId><ArticleId IdType="pmc">PMC7673708</ArticleId><ArticleId IdType="pubmed">33158864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, H., Rudge, D.G., Koos, J.D., Vaidialingam, B., Yang, H.J. and Pavletich, N.P. (2013) mTOR kinase structure, mechanism and regulation. Nature 497, 217&#x2013;223 10.1038/nature12122</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12122</ArticleId><ArticleId IdType="pmc">PMC4512754</ArticleId><ArticleId IdType="pubmed">23636326</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson, T.R., Laplante, M., Thoreen, C.C., Sancak, Y., Kang, S.A., Kuehl, W.M.et al. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873&#x2013;886 10.1016/j.cell.2009.03.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.046</ArticleId><ArticleId IdType="pmc">PMC2758791</ArticleId><ArticleId IdType="pubmed">19446321</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai, H., Wang, R.C., Takai, K.K., Yang, H. and de Lange, T. (2007) Tel2 regulates the stability of PI3K-related protein kinases. Cell 131, 1248&#x2013;1259 10.1016/j.cell.2007.10.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.052</ArticleId><ArticleId IdType="pubmed">18160036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K.et al. (2010) Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J. Biol. Chem. 285, 20109&#x2013;20116 10.1074/jbc.M110.121699</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.121699</ArticleId><ArticleId IdType="pmc">PMC2888423</ArticleId><ArticleId IdType="pubmed">20427287</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai, H., Xie, Y., de Lange, T. and Pavletich, N.P. (2010) Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes Dev. 24, 2019&#x2013;2030 10.1101/gad.1956410</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1956410</ArticleId><ArticleId IdType="pmc">PMC2939364</ArticleId><ArticleId IdType="pubmed">20801936</ArticleId></ArticleIdList></Reference><Reference><Citation>Toullec, D., Elias-Villalobos, A., Faux, C., Noly, A., Lledo, G., Seveno, M.et al. (2021) The Hsp90 cochaperone TTT promotes cotranslational maturation of PIKKs prior to complex assembly. Cell Rep. 37, 109867 10.1016/j.celrep.2021.109867</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109867</ArticleId><ArticleId IdType="pubmed">34686329</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble, C.C., Asara, J.M. and Manning, B.D. (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657&#x2013;5670 10.1128/MCB.00735-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00735-09</ArticleId><ArticleId IdType="pmc">PMC2772744</ArticleId><ArticleId IdType="pubmed">19720745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, P., Zhang, N., Nussinov, R. and Ma, B. (2015) Defining the domain arrangement of the mammalian target of rapamycin complex component Rictor protein. J. Comput. Biol. 22, 876&#x2013;886 10.1089/cmb.2015.0103</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cmb.2015.0103</ArticleId><ArticleId IdType="pmc">PMC4575542</ArticleId><ArticleId IdType="pubmed">26176550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, Y., Pan, B., Sun, H., Chen, G., Su, B. and Huang, Y. (2015) Characterization of Sin1 isoforms reveals an mTOR-dependent and independent function of Sin1&#x3b3;. PLoS One 10, e0135017 10.1371/journal.pone.0135017</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135017</ArticleId><ArticleId IdType="pmc">PMC4532406</ArticleId><ArticleId IdType="pubmed">26263164</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder, W., Cloonan, N., Bushell, G. and Sculley, T. (2004) Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 gene. Gene 339, 17&#x2013;23 10.1016/j.gene.2004.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2004.07.001</ArticleId><ArticleId IdType="pubmed">15363842</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Z., Chen, J., Takagi, E., Wang, F., Saha, B., Liu, X.et al. (2022) Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt. J. Biol. Chem. 298, 102288 10.1016/j.jbc.2022.102288</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102288</ArticleId><ArticleId IdType="pmc">PMC9440446</ArticleId><ArticleId IdType="pubmed">35926713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, M., Wang, J., Ives, H.E. and Pearce, D. (2011) mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel. J. Biol. Chem. 286, 30647&#x2013;30654 10.1074/jbc.M111.257592</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.257592</ArticleId><ArticleId IdType="pmc">PMC3162425</ArticleId><ArticleId IdType="pubmed">21757730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron, A.J., Linch, M.D., Saurin, A.T., Escribano, C. and Parker, P.J. (2011) mTORC2 targets AGC kinases through Sin1-dependent recruitment. Biochem. J. 439, 287&#x2013;297 10.1042/BJ20110678</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20110678</ArticleId><ArticleId IdType="pubmed">21806543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatebe, H., Murayama, S., Yonekura, T., Hatano, T., Richter, D., Furuya, T.et al. (2017) Substrate specificity of TOR complex 2 is determined by a ubiquitin-fold domain of the Sin1 subunit. eLife 6, e19594 10.7554/eLife.19594</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19594</ArticleId><ArticleId IdType="pmc">PMC5340527</ArticleId><ArticleId IdType="pubmed">28264193</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, B., Jie, Z., Joo, D., Ordureau, A., Liu, P., Gan, W.et al. (2017) TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature 545, 365&#x2013;369 10.1038/nature22344</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22344</ArticleId><ArticleId IdType="pmc">PMC5695540</ArticleId><ArticleId IdType="pubmed">28489822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, Y., Ding, L., Meng, X., Potter, M., Kearney, A.L., Zhang, J.et al. (2022) Structural insights into Ras regulation by SIN1. Proc. Natl Acad. Sci. U.S.A. 119, e2119990119 10.1073/pnas.2119990119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119990119</ArticleId><ArticleId IdType="pmc">PMC9171633</ArticleId><ArticleId IdType="pubmed">35522713</ArticleId></ArticleIdList></Reference><Reference><Citation>Castel, P., Dharmaiah, S., Sale, M.J., Messing, S., Rizzuto, G., Cuevas-Navarro, A.et al. (2021) RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity. Proc. Natl Acad. Sci. U.S.A. 118, e2103261118 10.1073/pnas.2103261118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2103261118</ArticleId><ArticleId IdType="pmc">PMC8379911</ArticleId><ArticleId IdType="pubmed">34380736</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder, W.A., Buck, M., Cloonan, N., Hancock, J.F., Suhrbier, A., Sculley, T.et al. (2007) Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. Cell Signal. 19, 1279&#x2013;1289 10.1016/j.cellsig.2007.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2007.01.013</ArticleId><ArticleId IdType="pubmed">17303383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, P., Gan, W., Chin, Y.R., Ogura, K., Guo, J., Zhang, J.et al. (2015) PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex. Cancer Discov. 5, 1194&#x2013;1209 10.1158/2159-8290.CD-15-0460</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-15-0460</ArticleId><ArticleId IdType="pmc">PMC4631654</ArticleId><ArticleId IdType="pubmed">26293922</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold, D. and Walther, T.C. (2009) TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain. Mol. Biol. Cell 20, 1565&#x2013;1575 10.1091/mbc.e08-10-1001</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-10-1001</ArticleId><ArticleId IdType="pmc">PMC2649262</ArticleId><ArticleId IdType="pubmed">19144819</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, P., Gan, W., Inuzuka, H., Lazorchak, A.S., Gao, D., Arojo, O.et al. (2013) Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat. Cell Biol. 15, 1340&#x2013;1350 10.1038/ncb2860</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2860</ArticleId><ArticleId IdType="pmc">PMC3827117</ArticleId><ArticleId IdType="pubmed">24161930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, Y., Kim, L.C., Song, W., Edwards, D.N., Cook, R.S. and Chen, J. (2019) Disruption of the scaffolding function of mLST8 selectively inhibits mTORC2 assembly and function and suppresses mTORC2-dependent tumor growth in vivo. Cancer Res. 79, 3178&#x2013;3184 10.1158/0008-5472.CAN-18-3658</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-3658</ArticleId><ArticleId IdType="pmc">PMC6606357</ArticleId><ArticleId IdType="pubmed">31085701</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuellar, J., Ludlam, W.G., Tensmeyer, N.C., Aoba, T., Dhavale, M., Santiago, C.et al. (2019) Structural and functional analysis of the role of the chaperonin CCT in mTOR complex assembly. Nat. Commun. 10, 2865 10.1038/s41467-019-10781-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10781-1</ArticleId><ArticleId IdType="pmc">PMC6599039</ArticleId><ArticleId IdType="pubmed">31253771</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J.Z., Zhu, H., You, P., Liu, H., Wang, W.K., Fan, X.et al. (2022) Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway. J. Clin. Invest. 132, e146536 10.1172/JCI146536</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146536</ArticleId><ArticleId IdType="pmc">PMC9012288</ArticleId><ArticleId IdType="pubmed">35239512</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce, L.R., Huang, X., Boudeau, J., Pawlowski, R., Wullschleger, S., Deak, M.et al. (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513&#x2013;522 10.1042/BJ20070540</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20070540</ArticleId><ArticleId IdType="pmc">PMC2267312</ArticleId><ArticleId IdType="pubmed">17461779</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce, L.R., Sommer, E.M., Sakamoto, K., Wullschleger, S. and Alessi, D.R. (2011) Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem. J. 436, 169&#x2013;179 10.1042/BJ20102103</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20102103</ArticleId><ArticleId IdType="pubmed">21413931</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo, S.Y., Kim, D.H., Jun, C.B., Kim, Y.M., Haar, E.V., Lee, S.I.et al. (2007) PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor &#x3b2; expression and signaling. J. Biol. Chem. 282, 25604&#x2013;25612 10.1074/jbc.M704343200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704343200</ArticleId><ArticleId IdType="pubmed">17599906</ArticleId></ArticleIdList></Reference><Reference><Citation>Walchli, M., Berneiser, K., Mangia, F., Imseng, S., Craigie, L.M., Stuttfeld, E.et al. (2021) Regulation of human mTOR complexes by DEPTOR. eLife 10, e70871 10.7554/eLife.70871</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70871</ArticleId><ArticleId IdType="pmc">PMC8439649</ArticleId><ArticleId IdType="pubmed">34519268</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron, A., Briscoe, D.M., Richard, D. and Laplante, M. (2018) DEPTOR at the nexus of cancer, metabolism, and immunity. Physiol. Rev. 98, 1765&#x2013;1803 10.1152/physrev.00064.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00064.2017</ArticleId><ArticleId IdType="pmc">PMC6335100</ArticleId><ArticleId IdType="pubmed">29897294</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, D., Inuzuka, H., Tan, M.K., Fukushima, H., Locasale, J.W., Liu, P.et al. (2011) mTOR drives its own activation via SCF&#x3b2;TrCP-dependent degradation of the mTOR inhibitor DEPTOR. Mol. Cell 44, 290&#x2013;303 10.1016/j.molcel.2011.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.08.030</ArticleId><ArticleId IdType="pmc">PMC3229299</ArticleId><ArticleId IdType="pubmed">22017875</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, X., Wang, L., Han, Z., Zhou, L., Shan, L., Ding, Y.et al. (2017) Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma. Exp. Cell Res. 353, 35&#x2013;45 10.1016/j.yexcr.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2017.03.003</ArticleId><ArticleId IdType="pubmed">28267437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X., Xiong, X., Cui, D., Yang, F., Wei, D., Li, H.et al. (2020) DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene 39, 1557&#x2013;1571 10.1038/s41388-019-1085-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-019-1085-y</ArticleId><ArticleId IdType="pmc">PMC7018663</ArticleId><ArticleId IdType="pubmed">31685947</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonneau M, L.M.G., Lalonde, M.E., Germain, M.A., Motorina, A., Guiot, M.C.et al. (2016) The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat. Commun. 7, 12700 10.1038/ncomms12700</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12700</ArticleId><ArticleId IdType="pmc">PMC5027283</ArticleId><ArticleId IdType="pubmed">27624942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalsky, A.H., Namkoong, S., Mettetal, E., Park, H.W., Kazyken, D., Fingar, D.C.et al. (2020) The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation. J. Biol. Chem. 295, 1769&#x2013;1780 10.1074/jbc.RA119.010857</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.010857</ArticleId><ArticleId IdType="pmc">PMC7029113</ArticleId><ArticleId IdType="pubmed">31915252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J.H., Budanov, A.V., Park, E.J., Birse, R., Kim, T.E., Perkins, G.A.et al. (2010) Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327, 1223&#x2013;1228 10.1126/science.1182228</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1182228</ArticleId><ArticleId IdType="pmc">PMC2866632</ArticleId><ArticleId IdType="pubmed">20203043</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchamp, E.M., Abedin, S.M., Radecki, S.G., Fischietti, M., Arslan, A.D., Blyth, G.T.et al. (2019) Identification and targeting of novel CDK9 complexes in acute myeloid leukemia. Blood 133, 1171&#x2013;1185 10.1182/blood-2018-08-870089</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-08-870089</ArticleId><ArticleId IdType="pmc">PMC6418475</ArticleId><ArticleId IdType="pubmed">30587525</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, P.C., Oloumi, A., Mills, J., Dobreva, I., Maidan, M., Gray, V.et al. (2008) Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 68, 1618&#x2013;1624 10.1158/0008-5472.CAN-07-5869</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-5869</ArticleId><ArticleId IdType="pubmed">18339839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan, G.N., Lin, Y., Magnuson, M.A., Avruch, J. and Czech, M.P. (2008) A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes. Mol. Cell. Biol. 28, 4215&#x2013;4226 10.1128/MCB.00867-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00867-07</ArticleId><ArticleId IdType="pmc">PMC2447144</ArticleId><ArticleId IdType="pubmed">18426911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, T., Du, X., Zhao, L., He, M., Lin, L., Guo, C.et al. (2019) SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription. FASEB J. 33, 14703&#x2013;14716 10.1096/fj.201900782R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900782R</ArticleId><ArticleId IdType="pubmed">31693862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M., Wu, J., Zhang, R., Yang, J., Zhang, Q. and Liu, B. (2019) miR-497 inhibits the carcinogenesis of hepatocellular carcinoma by targeting the Rictor/Akt signal pathway. Int. J. Clin. Exp. Pathol.
12, 1992&#x2013;2000 PubMed https://pubmed.ncbi.nlm.nih.gov/31934021/
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949653</ArticleId><ArticleId IdType="pubmed">31934021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendavit, G., Aboulkassim, T., Hilmi, K., Shah, S. and Batist, G. (2016) Nrf2 transcription factor can directly regulate mTOR: linking cytoprotective gene expression to a major metabolic regulator that generates redox activity. J. Biol. Chem. 291, 25476&#x2013;25488 10.1074/jbc.M116.760249</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.760249</ArticleId><ArticleId IdType="pmc">PMC5207248</ArticleId><ArticleId IdType="pubmed">27784786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, Z., Song, C., Ding, Y., Tan, B.H., Desai, D., Sharma, A.et al. (2021) Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia 35, 1267&#x2013;1278 10.1038/s41375-021-01132-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-021-01132-5</ArticleId><ArticleId IdType="pmc">PMC8102195</ArticleId><ArticleId IdType="pubmed">33531656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, B., Chen, L., Fu, H., Guo, L., Guo, H. and Zhang, N. (2016) Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-&#x3ba;B pathway contributes to the metastasis of renal cell carcinoma. Tumour Biol. 37, 4457&#x2013;4466 10.1007/s13277-015-4296-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-4296-z</ArticleId><ArticleId IdType="pubmed">26500094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, H., Chin, H., Kim, H., Jung, H. and Lee, D. (2020) STAT3-mediated MLST8 gene expression regulates cap-dependent translation in cancer cells. Mol. Oncol. 14, 1850&#x2013;1867 10.1002/1878-0261.12735</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1878-0261.12735</ArticleId><ArticleId IdType="pmc">PMC7400782</ArticleId><ArticleId IdType="pubmed">32495998</ArticleId></ArticleIdList></Reference><Reference><Citation>Panasyuk, G., Nemazanyy, I., Zhyvoloup, A., Filonenko, V., Davies, D., Robson, M.et al. (2009) mTOR&#x3b2; splicing isoform promotes cell proliferation and tumorigenesis. J. Biol. Chem. 284, 30807&#x2013;30814 10.1074/jbc.M109.056085</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.056085</ArticleId><ArticleId IdType="pmc">PMC2781479</ArticleId><ArticleId IdType="pubmed">19726679</ArticleId></ArticleIdList></Reference><Reference><Citation>Terenzio, M., Koley, S., Samra, N., Rishal, I., Zhao, Q., Sahoo, P.K.et al. (2018) Locally translated mTOR controls axonal local translation in nerve injury. Science 359, 1416&#x2013;1421 10.1126/science.aan1053</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan1053</ArticleId><ArticleId IdType="pmc">PMC6501578</ArticleId><ArticleId IdType="pubmed">29567716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabanella, F., Barbato, C., Fiore, M., Petrella, C., de Vincentiis, M., Greco, A.et al. (2021) Fine-tuning of mTOR mRNA and nucleolin complexes by SMN. Cells 10, 3015 10.3390/cells10113015</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113015</ArticleId><ArticleId IdType="pmc">PMC8616268</ArticleId><ArticleId IdType="pubmed">34831238</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M.L., Ragupathi, A., Patel, N., Hernandez, T., Magsino, J., Werlen, G.et al. (2022) The RNA-binding protein AUF1 facilitates Akt phosphorylation at the membrane. J. Biol. Chem. 298, 102437 10.1016/j.jbc.2022.102437</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102437</ArticleId><ArticleId IdType="pmc">PMC9513781</ArticleId><ArticleId IdType="pubmed">36041631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Y., Geng, H., Liu, G., Ji, Q., Cheng, X., Li, X.et al. (2021) The deubiquitinase USP39 promotes ESCC tumorigenesis through pre-mRNA splicing of the mTORC2 component rictor. Front. Oncol. 11, 667495 10.3389/fonc.2021.667495</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.667495</ArticleId><ArticleId IdType="pmc">PMC8189149</ArticleId><ArticleId IdType="pubmed">34123832</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, B., Benavides-Serrato, A., Freeman, R.S., Landon, K.A., Bashir, T., Nishimura, R.N.et al. (2018) mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma. Oncogene 37, 732&#x2013;743 10.1038/onc.2017.360</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2017.360</ArticleId><ArticleId IdType="pmc">PMC5805585</ArticleId><ArticleId IdType="pubmed">29059166</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, B., Wu, K., Zeng, J., Xu, S., Mu, L., Gao, Y.et al. (2017) Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer. Oncotarget 8, 8162&#x2013;8172 10.18632/oncotarget.14131</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14131</ArticleId><ArticleId IdType="pmc">PMC5352391</ArticleId><ArticleId IdType="pubmed">28030804</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui, Y., Zhao, J., Yi, L. and Jiang, Y. (2016) microRNA-153 targets mTORC2 component rictor to inhibit glioma cells. PLoS One 11, e0156915 10.1371/journal.pone.0156915</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156915</ArticleId><ArticleId IdType="pmc">PMC4905671</ArticleId><ArticleId IdType="pubmed">27295037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H.H., Huang, W.T., Yang, L.W. and Lin, C.W. (2015) The PTEN-AKT-mTOR/RICTOR pathway in nasal natural killer cell lymphoma is activated by miR-494-3p via PTEN but inhibited by miR-142-3p via RICTOR. Am. J. Pathol. 185, 1487&#x2013;1499 10.1016/j.ajpath.2015.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.01.025</ArticleId><ArticleId IdType="pubmed">25907832</ArticleId></ArticleIdList></Reference><Reference><Citation>Micevic, G., Muthusamy, V., Damsky, W., Theodosakis, N., Liu, X., Meeth, K.et al. (2016) DNMT3b modulates melanoma growth by controlling levels of mTORC2 component RICTOR. Cell Rep. 14, 2180&#x2013;2192 10.1016/j.celrep.2016.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.02.010</ArticleId><ArticleId IdType="pmc">PMC4785087</ArticleId><ArticleId IdType="pubmed">26923591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, Y., Tang, X., Ren, Y., Yang, Y., Song, F., Fu, J.et al. (2021) An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity. Signal Transduct. Target. Ther. 6, 421 10.1038/s41392-021-00801-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00801-2</ArticleId><ArticleId IdType="pmc">PMC8677721</ArticleId><ArticleId IdType="pubmed">34916485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C.J., Cheng, P., Liang, M.K., Chen, Y.S., Lu, Q., Wang, J.Y.et al. (2015) MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Invest. 125, 1509&#x2013;1522 10.1172/JCI77716</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI77716</ArticleId><ArticleId IdType="pmc">PMC4396470</ArticleId><ArticleId IdType="pubmed">25751060</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Zhang, Y., Zheng, M., Cao, X., Guo, M., Gao, X.et al. (2022) miR-582 negatively regulates pre-B cell proliferation and survival through targeting Hif1&#x3b1; and Rictor. Cell Death Dis. 13, 107 10.1038/s41419-022-04560-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04560-y</ArticleId><ArticleId IdType="pmc">PMC8814019</ArticleId><ArticleId IdType="pubmed">35115499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D., Nguyen, Q.T., Lee, J., Lee, S.H., Janocha, A., Kim, S.et al. (2020) Anti-inflammatory roles of glucocorticoids are mediated by Foxp3+ regulatory T cells via a miR-342-dependent mechanism. Immunity 53, 581&#x2013;596.e5 10.1016/j.immuni.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7793548</ArticleId><ArticleId IdType="pubmed">32707034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q., Zhu, J., Wang, Y.W., Dai, Y., Wang, Y.L., Wang, C.et al. (2017) Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma. Oncogene 36, 6225&#x2013;6234 10.1038/onc.2017.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2017.228</ArticleId><ArticleId IdType="pmc">PMC5680133</ArticleId><ArticleId IdType="pubmed">28692058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, S., Lv, Q., Xu, F., Li, H. and Guo, X. (2022) LncRNA CASC9-1 facilitates cell malignant behaviors in cervical squamous cell carcinoma by targeting miR-383-5p to up-regulate MAPKAP1. Arch. Med. Res. 53, 138&#x2013;146 10.1016/j.arcmed.2021.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.10.008</ArticleId><ArticleId IdType="pubmed">34857398</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu, Z., Hu, Y., Raizada, D., Bassal, M.A., Tenen, D.G. and Karnoub, A.E. (2022) Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer. Proc. Natl Acad. Sci. U.S.A. 119, e2203180119 10.1073/pnas.2203180119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203180119</ArticleId><ArticleId IdType="pmc">PMC9618063</ArticleId><ArticleId IdType="pubmed">36269860</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, B., Artinian, N., Anderson, L., Martin, J., Masri, J., Cloninger, C.et al. (2012) Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress. Cell Signal. 24, 309&#x2013;315 10.1016/j.cellsig.2011.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2011.09.015</ArticleId><ArticleId IdType="pmc">PMC3205320</ArticleId><ArticleId IdType="pubmed">21964062</ArticleId></ArticleIdList></Reference><Reference><Citation>Holz, M.K. and Blenis, J. (2005) Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J. Biol. Chem. 280, 26089&#x2013;26093 10.1074/jbc.M504045200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504045200</ArticleId><ArticleId IdType="pubmed">15905173</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds, T., Bodine, S.C. and Lawrence, Jr, J.C. (2002) Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem. 277, 17657&#x2013;17662 10.1074/jbc.M201142200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M201142200</ArticleId><ArticleId IdType="pubmed">11884412</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave, B.T., Ouwens, M., Withers, D.J., Alessi, D.R. and Shepherd, P.R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344 (Pt 2), 427&#x2013;431 10.1042/bj3440427</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3440427</ArticleId><ArticleId IdType="pmc">PMC1220660</ArticleId><ArticleId IdType="pubmed">10567225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang, G.G. and Abraham, R.T. (2005) Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485&#x2013;25490 10.1074/jbc.M501707200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501707200</ArticleId><ArticleId IdType="pubmed">15899889</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, S.W., Fryer, L.G., Carling, D. and Shepherd, P.R. (2004) Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279, 15719&#x2013;15722 10.1074/jbc.C300534200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C300534200</ArticleId><ArticleId IdType="pubmed">14970221</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson, R.T., Beal, P.A., Comb, M.J. and Schreiber, S.L. (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 275, 7416&#x2013;7423 10.1074/jbc.275.10.7416</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.10.7416</ArticleId><ArticleId IdType="pubmed">10702316</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman, G.A., Acosta-Jaquez, H.A., Dunlop, E.A., Ekim, B., Maj, N.E., Tee, A.R.et al. (2010) mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. J. Biol. Chem. 285, 7866&#x2013;7879 10.1074/jbc.M109.096222</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.096222</ArticleId><ArticleId IdType="pmc">PMC2832937</ArticleId><ArticleId IdType="pubmed">20022946</ArticleId></ArticleIdList></Reference><Reference><Citation>Copp, J., Manning, G. and Hunter, T. (2009) TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 69, 1821&#x2013;1827 10.1158/0008-5472.CAN-08-3014</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-3014</ArticleId><ArticleId IdType="pmc">PMC2652681</ArticleId><ArticleId IdType="pubmed">19244117</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, W.J., Wu, C.C., Kim, S.J., Facchinetti, V., Julien, L.A., Finlan, M.et al. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29, 3939&#x2013;3951 10.1038/emboj.2010.271</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.271</ArticleId><ArticleId IdType="pmc">PMC3020639</ArticleId><ArticleId IdType="pubmed">21045808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekim, B., Magnuson, B., Acosta-Jaquez, H.A., Keller, J.A., Feener, E.P. and Fingar, D.C. (2011) mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Mol. Cell. Biol. 31, 2787&#x2013;2801 10.1128/MCB.05437-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.05437-11</ArticleId><ArticleId IdType="pmc">PMC3133410</ArticleId><ArticleId IdType="pubmed">21576368</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Jaquez, H.A., Keller, J.A., Foster, K.G., Ekim, B., Soliman, G.A., Feener, E.P.et al. (2009) Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth. Mol. Cell. Biol. 29, 4308&#x2013;4324 10.1128/MCB.01665-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01665-08</ArticleId><ArticleId IdType="pmc">PMC2715808</ArticleId><ArticleId IdType="pubmed">19487463</ArticleId></ArticleIdList></Reference><Reference><Citation>Tooley, A.S., Kazyken, D., Bodur, C., Gonzalez, I.E. and Fingar, D.C. (2021) The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. J. Biol. Chem. 297, 100942 10.1016/j.jbc.2021.100942</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100942</ArticleId><ArticleId IdType="pmc">PMC8342794</ArticleId><ArticleId IdType="pubmed">34245780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodur, C., Kazyken, D., Huang, K., Ekim Ustunel, B., Siroky, K.A., Tooley, A.S.et al. (2018) The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists. EMBO J. 37, 19&#x2013;38 10.15252/embj.201696164</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696164</ArticleId><ArticleId IdType="pmc">PMC5753041</ArticleId><ArticleId IdType="pubmed">29150432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodur, C., Kazyken, D., Huang, K., Tooley, A.S., Cho, K.W., Barnes, T.M.et al. (2022) TBK1-mTOR signaling attenuates obesity-linked hyperglycemia and insulin resistance. Diabetes 71, 2297&#x2013;2312 10.2337/db22-0256</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db22-0256</ArticleId><ArticleId IdType="pmc">PMC9630091</ArticleId><ArticleId IdType="pubmed">35983955</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao, J.H., Kim, I.J., Wu, D., Climent, J., Kang, H.C., DelRosario, R.et al. (2008) FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321, 1499&#x2013;1502 10.1126/science.1162981</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1162981</ArticleId><ArticleId IdType="pmc">PMC2849753</ArticleId><ArticleId IdType="pubmed">18787170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, M.K., Zhang, C., Zhang, N., He, P., Cai, H.Y., Li, S.et al. (2023) The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency. Cell Metab. 35, 2216&#x2013;2230.e8 10.1016/j.cmet.2023.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2023.10.016</ArticleId><ArticleId IdType="pubmed">37979583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruning, U., Morales-Rodriguez, F., Kalucka, J., Goveia, J., Taverna, F., Queiroz, K.C.S.et al. (2018) Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation. Cell Metab. 28, 866&#x2013;880.e15 10.1016/j.cmet.2018.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.07.019</ArticleId><ArticleId IdType="pmc">PMC8057116</ArticleId><ArticleId IdType="pubmed">30146486</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien, L.A., Carriere, A., Moreau, J. and Roux, P.P. (2010) mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30, 908&#x2013;921 10.1128/MCB.00601-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00601-09</ArticleId><ArticleId IdType="pmc">PMC2815569</ArticleId><ArticleId IdType="pubmed">19995915</ArticleId></ArticleIdList></Reference><Reference><Citation>Treins, C., Warne, P.H., Magnuson, M.A., Pende, M. and Downward, J. (2009) Rictor is a novel target of p70 S6 kinase-1. Oncogene 29, 1003&#x2013;1016 10.1038/onc.2009.401</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2009.401</ArticleId><ArticleId IdType="pubmed">19935711</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya, K., Maiti, S. and Mandal, C. (2016) PTEN negatively regulates mTORC2 formation and signaling in grade IV glioma via Rictor hyperphosphorylation at Thr1135 and direct the mode of action of an mTORC1/2 inhibitor. Oncogenesis 5, e227 10.1038/oncsis.2016.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oncsis.2016.34</ArticleId><ArticleId IdType="pmc">PMC4945751</ArticleId><ArticleId IdType="pubmed">27239959</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo, J., Wu, X., Mao, Z., Khuri, F.R. and Sun, S.Y. (2015) Rictor undergoes glycogen synthase kinase 3 (GSK3)-dependent, FBXW7-mediated ubiquitination and proteasomal degradation. J. Biol. Chem. 290, 14120&#x2013;14129 10.1074/jbc.M114.633057</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.633057</ArticleId><ArticleId IdType="pmc">PMC4447982</ArticleId><ArticleId IdType="pubmed">25897075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C.H., Shaikenov, T., Peterson, T.R., Aimbetov, R., Bissenbaev, A.K., Lee, S.W.et al. (2011) ER stress inhibits mTORC2 and Akt signaling through GSK-3&#x3b2;-mediated phosphorylation of rictor. Sci. Signal. 4, ra10 10.1126/scisignal.2001731</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2001731</ArticleId><ArticleId IdType="pubmed">21343617</ArticleId></ArticleIdList></Reference><Reference><Citation>Glidden, E.J., Gray, L.G., Vemuru, S., Li, D., Harris, T.E. and Mayo, M.W. (2012) Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. J. Biol. Chem. 287, 581&#x2013;588 10.1074/jbc.M111.304337</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.304337</ArticleId><ArticleId IdType="pmc">PMC3249112</ArticleId><ArticleId IdType="pubmed">22084251</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui, K., Tanaka, K., Ikegami, S., Villa, G.R., Yang, H., Yong, W.H.et al. (2015) Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. Proc. Natl Acad. Sci. U.S.A. 112, 9406&#x2013;9411 10.1073/pnas.1511759112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1511759112</ArticleId><ArticleId IdType="pmc">PMC4522814</ArticleId><ArticleId IdType="pubmed">26170313</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, B.K., Sinha, R.A., Zhou, J., Tripathi, M., Ohba, K., Wang, M.E.et al. (2016) Hepatic FOXO1 target genes are co-regulated by thyroid hormone via RICTOR protein deacetylation and MTORC2-AKT protein inhibition. J. Biol. Chem. 291, 198&#x2013;214 10.1074/jbc.M115.668673</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.668673</ArticleId><ArticleId IdType="pmc">PMC4697156</ArticleId><ArticleId IdType="pubmed">26453307</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning, J.R., Thapa, D., Zhang, M., Stoner, M.W., Traba, J., Corey, C.et al. (2019) Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling. Biochem. J. 476, 1713&#x2013;1724 10.1042/BCJ20190302</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20190302</ArticleId><ArticleId IdType="pmc">PMC6636327</ArticleId><ArticleId IdType="pubmed">31138772</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, S., Wang, G., Chen, L., Geng, H., Zheng, Y., Xia, C.et al. (2023) Pharmacological vitamin C inhibits mTOR signaling and tumor growth by degrading Rictor and inducing HMOX1 expression. PLoS Genet. 19, e1010629 10.1371/journal.pgen.1010629</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010629</ArticleId><ArticleId IdType="pmc">PMC9928125</ArticleId><ArticleId IdType="pubmed">36787291</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, W., Hua, H., Chiu, Y.H., Li, G., Zhi, H., Yu, Z.et al. (2019) CD146 regulates growth factor-induced mTORC2 activity independent of the PI3K and mTORC1 pathways. Cell Rep. 29, 1311&#x2013;1322.e5 10.1016/j.celrep.2019.09.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.047</ArticleId><ArticleId IdType="pubmed">31665642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrobel, L., Siddiqi, F.H., Hill, S.M., Son, S.M., Karabiyik, C., Kim, H.et al. (2020) mTORC2 assembly is regulated by USP9X-mediated deubiquitination of RICTOR. Cell Rep. 33, 108564 10.1016/j.celrep.2020.108564</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108564</ArticleId><ArticleId IdType="pubmed">33378666</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal, P., Chen, Y.T., Schilling, B., Gibson, B.W. and Hughes, R.E. (2012) Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR). J. Biol. Chem. 287, 21164&#x2013;21175 10.1074/jbc.M111.328021</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.328021</ArticleId><ArticleId IdType="pmc">PMC3375539</ArticleId><ArticleId IdType="pubmed">22544753</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey, S.J., Yang, G., Yang, P., Fazakerley, D.J., Stockli, J., Yang, J.Y.et al. (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab. 17, 1009&#x2013;1020 10.1016/j.cmet.2013.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.04.010</ArticleId><ArticleId IdType="pmc">PMC3690479</ArticleId><ArticleId IdType="pubmed">23684622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, G., Murashige, D.S., Humphrey, S.J. and James, D.E. (2015) A positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation. Cell Rep. 12, 937&#x2013;943 10.1016/j.celrep.2015.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.07.016</ArticleId><ArticleId IdType="pubmed">26235620</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathy, G., Guan, J., Gustafsson, D.E., Javanmardi, N., Cervantes-Madrid, D., Djos, A.et al. (2017) MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Sci. Signal. 10, eaam7550 10.1126/scisignal.aam7550</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aam7550</ArticleId><ArticleId IdType="pubmed">29184034</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C.H., Kiyan, V., Zhylkibayev, A.A., Kazyken, D., Bulgakova, O., Page, K.E.et al. (2013) Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism. J. Biol. Chem. 288, 27019&#x2013;27030 10.1074/jbc.M113.498055</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.498055</ArticleId><ArticleId IdType="pmc">PMC3779703</ArticleId><ArticleId IdType="pubmed">23928304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason, C.E., Oses-Prieto, J.A., Li, K.H., Saha, B., Situ, G., Burlingame, A.L.et al. (2019) Phosphorylation at distinct subcellular locations underlies specificity in mTORC2-mediated activation of SGK1 and Akt. J. Cell Sci. 132, jcs224931 10.1242/jcs.224931</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.224931</ArticleId><ArticleId IdType="pmc">PMC6467483</ArticleId><ArticleId IdType="pubmed">30837283</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, L., Dai, X., Yin, S., Liu, P., Hill, E.G.. Wei, W., et al. (2022) DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway. Sci. Signal. 15, eabh2290 10.1126/scisignal.abh2290</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abh2290</ArticleId><ArticleId IdType="pmc">PMC8992387</ArticleId><ArticleId IdType="pubmed">34982576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghomlaghi, M., Yang, G., Shin, S.Y., James, D.E. and Nguyen, L.K. (2021) Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1. PLoS Comput. Biol. 17, e1008513 10.1371/journal.pcbi.1008513</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008513</ArticleId><ArticleId IdType="pmc">PMC8478217</ArticleId><ArticleId IdType="pubmed">34529665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, E., Chen, S., Tang, H., Fei, C., Yuan, Z., Mu, X.et al. (2022) CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma. Cancer Sci. 113, 91&#x2013;108 10.1111/cas.15188</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.15188</ArticleId><ArticleId IdType="pmc">PMC8748215</ArticleId><ArticleId IdType="pubmed">34741373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebner, M., Sinkovics, B., Szczygiel, M., Ribeiro, D.W. and Yudushkin, I. (2017) Localization of mTORC2 activity inside cells. J. Cell Biol. 216, 343&#x2013;353 10.1083/jcb.201610060</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201610060</ArticleId><ArticleId IdType="pmc">PMC5294791</ArticleId><ArticleId IdType="pubmed">28143890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pudewell, S., Lissy, J., Nakhaeizadeh, H., Mosaddeghzadeh, N., Nakhaei-Rad, S., Dvorsky, R.et al. (2022) New mechanistic insights into the RAS-SIN1 interaction at the membrane. Front. Cell Dev. Biol. 10, 987754 10.3389/fcell.2022.987754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.987754</ArticleId><ArticleId IdType="pmc">PMC9583166</ArticleId><ArticleId IdType="pubmed">36274845</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez Marshall, M.N., Emmerstorfer-Augustin, A., Leskoske, K.L., Zhang, L.H., Li, B. and Thorner, J. (2019) Analysis of the roles of phosphatidylinositol-4,5-bisphosphate and individual subunits in assembly, localization, and function of Saccharomyces cerevisiae target of rapamycin complex 2. Mol. Biol. Cell 30, 1555&#x2013;1574 10.1091/mbc.E18-10-0682</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E18-10-0682</ArticleId><ArticleId IdType="pmc">PMC6724684</ArticleId><ArticleId IdType="pubmed">30969890</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokoe, D., Stephens, L.R., Copeland, T., Gaffney, P.R., Reese, C.B., Painter, G.F.et al. (1997) Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567&#x2013;570 10.1126/science.277.5325.567</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.277.5325.567</ArticleId><ArticleId IdType="pubmed">9228007</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Gaffney, P.R., Reese, C.B.et al. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B&#x3b1;. Curr. Biol. 7, 261&#x2013;269 10.1016/S0960-9822(06)00122-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(06)00122-9</ArticleId><ArticleId IdType="pubmed">9094314</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G.F., Holmes, A.B.et al. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710&#x2013;714 10.1126/science.279.5351.710</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5351.710</ArticleId><ArticleId IdType="pubmed">9445477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellacosa, A., Chan, T.O., Ahmed, N.N., Datta, K., Malstrom, S., Stokoe, D.et al. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313&#x2013;325 10.1038/sj.onc.1201947</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1201947</ArticleId><ArticleId IdType="pubmed">9690513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohn, A.D., Barthel, A., Kovacina, K.S., Boge, A., Wallach, B., Summers, S.A.et al. (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J. Biol. Chem. 273, 11937&#x2013;11943 10.1074/jbc.273.19.11937</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.19.11937</ArticleId><ArticleId IdType="pubmed">9565622</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheid, M.P., Marignani, P.A. and Woodgett, J.R. (2002) Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol. Cell. Biol. 22, 6247&#x2013;6260 10.1128/MCB.22.17.6247-6260.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.17.6247-6260.2002</ArticleId><ArticleId IdType="pmc">PMC134003</ArticleId><ArticleId IdType="pubmed">12167717</ArticleId></ArticleIdList></Reference><Reference><Citation>Partovian, C., Ju, R., Zhuang, Z.W., Martin, K.A. and Simons, M. (2008) Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKC&#x3b1;-dependent manner in endothelial cells. Mol. Cell 32, 140&#x2013;149 10.1016/j.molcel.2008.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.09.010</ArticleId><ArticleId IdType="pmc">PMC2578831</ArticleId><ArticleId IdType="pubmed">18851840</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulbes, D.R., Shaiken, T. and Sarbassov dos, D. (2011) Endoplasmic reticulum is a main localization site of mTORC2. Biochem. Biophys. Res. Commun. 413, 46&#x2013;52 10.1016/j.bbrc.2011.08.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.08.034</ArticleId><ArticleId IdType="pmc">PMC3225125</ArticleId><ArticleId IdType="pubmed">21867682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinzalla, V., Stracka, D., Oppliger, W. and Hall, M.N. (2011) Activation of mTORC2 by association with the ribosome. Cell 144, 757&#x2013;768 10.1016/j.cell.2011.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.014</ArticleId><ArticleId IdType="pubmed">21376236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H.K., Bhattarai, K.R., Junjappa, R.P., Ahn, J.H., Pagire, S.H., Yoo, H.J.et al. (2020) TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation. Nat. Commun. 11, 4012 10.1038/s41467-020-17802-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17802-4</ArticleId><ArticleId IdType="pmc">PMC7419509</ArticleId><ArticleId IdType="pubmed">32782388</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz, C., Stracka, D., Prescianotto-Baschong, C., Frieden, M., Demaurex, N. and Hall, M.N. (2013) Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc. Natl Acad. Sci. U.S.A. 110, 12526&#x2013;12534 10.1073/pnas.1302455110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1302455110</ArticleId><ArticleId IdType="pmc">PMC3732980</ArticleId><ArticleId IdType="pubmed">23852728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bantug, G.R., Fischer, M., Grahlert, J., Balmer, M.L., Unterstab, G., Develioglu, L.et al. (2018) Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T cells. Immunity 48, 542&#x2013;555.e6 10.1016/j.immuni.2018.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.02.012</ArticleId><ArticleId IdType="pmc">PMC6049611</ArticleId><ArticleId IdType="pubmed">29523440</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Lopez, N., Mattar, P., Toledo, M., Bains, H., Kalyani, M., Aoun, M.L.et al. (2023) mTORC2-NDRG1-CDC42 axis couples fasting to mitochondrial fission. Nat. Cell Biol. 25, 989&#x2013;1003 10.1038/s41556-023-01163-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01163-3</ArticleId><ArticleId IdType="pmc">PMC10344787</ArticleId><ArticleId IdType="pubmed">37386153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia, R. and Bonifacino, J.S. (2019) Lysosome positioning influences mTORC2 and AKT signaling. Mol. Cell 75, 26&#x2013;38.e3 10.1016/j.molcel.2019.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.05.009</ArticleId><ArticleId IdType="pmc">PMC7446307</ArticleId><ArticleId IdType="pubmed">31130364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, M., Choi, S., Jung, O., Wen, T., Baum, C., Thapa, N.et al. (2019) The specificity of EGF-stimulated IQGAP1 scaffold towards the PI3K-Akt pathway is defined by the IQ3 motif. Sci. Rep. 9, 9126 10.1038/s41598-019-45671-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45671-5</ArticleId><ArticleId IdType="pmc">PMC6591252</ArticleId><ArticleId IdType="pubmed">31235839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, M., Choi, S., Wen, T., Chen, C., Thapa, N., Lee, J.H.et al. (2022) A p53-phosphoinositide signalosome regulates nuclear AKT activation. Nat. Cell Biol. 24, 1099&#x2013;1113 10.1038/s41556-022-00949-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-022-00949-1</ArticleId><ArticleId IdType="pmc">PMC9833102</ArticleId><ArticleId IdType="pubmed">35798843</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, S., Hedman, A.C., Sayedyahossein, S., Thapa, N., Sacks, D.B. and Anderson, R.A. (2016) Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases. Nat. Cell Biol. 18, 1324&#x2013;1335 10.1038/ncb3441</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3441</ArticleId><ArticleId IdType="pmc">PMC5679705</ArticleId><ArticleId IdType="pubmed">27870828</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, M.C. and Shulman, G.I. (2018) Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133&#x2013;2223 10.1152/physrev.00063.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00063.2017</ArticleId><ArticleId IdType="pmc">PMC6170977</ArticleId><ArticleId IdType="pubmed">30067154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawse, W.F. and Cattley, R.T. (2019) T cells transduce T-cell receptor signal strength by generating different phosphatidylinositols. J. Biol. Chem. 294, 4793&#x2013;4805 10.1074/jbc.RA118.006524</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006524</ArticleId><ArticleId IdType="pmc">PMC6442064</ArticleId><ArticleId IdType="pubmed">30692200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan, X., Wang, J., Su, B. and Wu, D. (2011) Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 286, 10998&#x2013;11002 10.1074/jbc.M110.195016</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.195016</ArticleId><ArticleId IdType="pmc">PMC3064154</ArticleId><ArticleId IdType="pubmed">21310961</ArticleId></ArticleIdList></Reference><Reference><Citation>Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C.et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932&#x2013;1943 10.1038/emboj.2008.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2008.120</ArticleId><ArticleId IdType="pmc">PMC2486276</ArticleId><ArticleId IdType="pubmed">18566586</ArticleId></ArticleIdList></Reference><Reference><Citation>Senoo, H., Murata, D., Wai, M., Arai, K., Iwata, W., Sesaki, H.et al. (2021) KARATE: PKA-induced KRAS4B-RHOA-mTORC2 supercomplex phosphorylates AKT in insulin signaling and glucose homeostasis. Mol. Cell 81, 4622&#x2013;4634.e8 10.1016/j.molcel.2021.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.09.001</ArticleId><ArticleId IdType="pubmed">34551282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bago, R., Malik, N., Munson, M.J., Prescott, A.R., Davies, P., Sommer, E.et al. (2014) Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem. J. 463, 413&#x2013;427 10.1042/BJ20140889</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20140889</ArticleId><ArticleId IdType="pmc">PMC4209782</ArticleId><ArticleId IdType="pubmed">25177796</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, N., Macartney, T., Hornberger, A., Anderson, K.E., Tovell, H., Prescott, A.R.et al. (2018) Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks. Biochem. J. 475, 117&#x2013;135 10.1042/BCJ20170650</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20170650</ArticleId><ArticleId IdType="pmc">PMC5748840</ArticleId><ArticleId IdType="pubmed">29150437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, M., Dehvari, N., Oberg, A.I., Dallner, O.S., Sandstrom, A.L., Olsen, J.M.et al. (2014) Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 63, 4115&#x2013;4129 10.2337/db13-1860</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1860</ArticleId><ArticleId IdType="pubmed">25008179</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen, J.M., Sato, M., Dallner, O.S., Sandstrom, A.L., Pisani, D.F., Chambard, J.C.et al. (2014) Glucose uptake in brown fat cells is dependent on mTOR complex 2-promoted GLUT1 translocation. J. Cell Biol. 207, 365&#x2013;374 10.1083/jcb.201403080</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201403080</ArticleId><ArticleId IdType="pmc">PMC4226734</ArticleId><ArticleId IdType="pubmed">25385184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, M., Evans, B.A., Sandstrom, A.L., Chia, L.Y., Mukaida, S., Thai, B.S.et al. (2018) &#x3b1;1A-Adrenoceptors activate mTOR signalling and glucose uptake in cardiomyocytes. Biochem. Pharmacol. 148, 27&#x2013;40 10.1016/j.bcp.2017.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.11.016</ArticleId><ArticleId IdType="pubmed">29175420</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert, V., Svensson, K., Shimobayashi, M., Colombi, M., Munoz, S., Jimenez, V.et al. (2016) mTORC2 sustains thermogenesis via Akt-induced glucose uptake and glycolysis in brown adipose tissue. EMBO Mol. Med. 8, 232&#x2013;246 10.15252/emmm.201505610</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201505610</ArticleId><ArticleId IdType="pmc">PMC4772955</ArticleId><ArticleId IdType="pubmed">26772600</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra, U.K. and Pizzo, S.V. (2012) Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex. J. Cell. Biochem. 113, 1488&#x2013;1500 10.1002/jcb.24018</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.24018</ArticleId><ArticleId IdType="pubmed">22173835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, A., Kupiec, M. and Weisman, R. (2014) Glucose activates TORC2-Gad8 protein via positive regulation of the cAMP/cAMP-dependent protein kinase A (PKA) pathway and negative regulation of the Pmk1 protein-mitogen-activated protein kinase pathway. J. Biol. Chem. 289, 21727&#x2013;21737 10.1074/jbc.M114.573824</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.573824</ArticleId><ArticleId IdType="pmc">PMC4118131</ArticleId><ArticleId IdType="pubmed">24928510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, T., Holleman, C.L., Nason, S., Arble, D.M., Ottaway, N., Chabenne, J.et al. (2018) Hepatic glucagon receptor signaling enhances insulin-stimulated glucose disposal in rodents. Diabetes 67, 2157&#x2013;2166 10.2337/db18-0068</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db18-0068</ArticleId><ArticleId IdType="pmc">PMC6198333</ArticleId><ArticleId IdType="pubmed">30150304</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles-Molina, E., Dionisio-Vicuna, M., Guzman-Hernandez, M.L., Reyes-Cruz, G. and Vazquez-Prado, J. (2014) G&#x3b2;&#x3b3; interacts with mTOR and promotes its activation. Biochem. Biophys. Res. Commun. 444, 218&#x2013;223 10.1016/j.bbrc.2014.01.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.01.044</ArticleId><ArticleId IdType="pubmed">24462769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan, X., Wang, J., Wang, C., Sommer, E., Kozasa, T., Srinivasula, S.et al. (2012) PRR5L degradation promotes mTORC2-mediated PKC-&#x3b4; phosphorylation and cell migration downstream of G&#x3b1;12. Nat. Cell Biol. 14, 686&#x2013;696 10.1038/ncb2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2507</ArticleId><ArticleId IdType="pmc">PMC3389271</ArticleId><ArticleId IdType="pubmed">22609986</ArticleId></ArticleIdList></Reference><Reference><Citation>Tato, I., Bartrons, R., Ventura, F. and Rosa, J.L. (2011) Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J. Biol. Chem. 286, 6128&#x2013;6142 10.1074/jbc.M110.166991</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.166991</ArticleId><ArticleId IdType="pmc">PMC3057817</ArticleId><ArticleId IdType="pubmed">21131356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazyken, D., Lentz, S.I. and Fingar, D.C. (2021) Alkaline intracellular pH (pHi) activates AMPK-mTORC2 signaling to promote cell survival during growth factor limitation. J. Biol. Chem. 297, 101100 10.1016/j.jbc.2021.101100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101100</ArticleId><ArticleId IdType="pmc">PMC8479482</ArticleId><ArticleId IdType="pubmed">34418433</ArticleId></ArticleIdList></Reference><Reference><Citation>Merhi, A., Delree, P. and Marini, A.M. (2017) The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling. Sci. Rep. 7, 44602 10.1038/srep44602</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44602</ArticleId><ArticleId IdType="pmc">PMC5355986</ArticleId><ArticleId IdType="pubmed">28303961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazyken, D., Magnuson, B., Bodur, C., Acosta-Jaquez, H.A., Zhang, D., Tong, X.et al. (2019) AMPK directly activates mTORC2 to promote cell survival during acute energetic stress. Sci. Signal. 12, eaav3249 10.1126/scisignal.aav3249</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aav3249</ArticleId><ArticleId IdType="pmc">PMC6935248</ArticleId><ArticleId IdType="pubmed">31186373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazyken, D., Lentz, S.I., Wadley, M. and Fingar, D.C. (2023) Alkaline intracellular pH (pHi) increases PI3K kinase activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. J. Biol. Chem. 299, 105097 10.1016/j.jbc.2023.105097</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.105097</ArticleId><ArticleId IdType="pmc">PMC10477693</ArticleId><ArticleId IdType="pubmed">37507012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, G., Chen, L., Qin, S., Zheng, Y., Xia, C., Yao, J.et al. (2022) Cystine induced-mTORC2 activation through promoting Sin1 phosphorylation to suppress cancer cell ferroptosis. Mol. Nutr. Food Res. 66, e2200186 10.1002/mnfr.202200186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.202200186</ArticleId><ArticleId IdType="pubmed">36189894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson, R.L. and Sabatini, D.M. (2017) The Dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 26, 301&#x2013;309 10.1016/j.cmet.2017.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.07.001</ArticleId><ArticleId IdType="pmc">PMC5560103</ArticleId><ArticleId IdType="pubmed">28768171</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloughney, J.G., Kim, P.K., Vega-Cotto, N.M., Wu, C.C., Zhang, S., Adlam, M.et al. (2016) mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1. Mol. Cell 63, 811&#x2013;826 10.1016/j.molcel.2016.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.07.015</ArticleId><ArticleId IdType="pmc">PMC5006067</ArticleId><ArticleId IdType="pubmed">27570073</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloughney, J.G., Vega-Cotto, N.M., Liu, S., Patel, C., Kim, P.K., Wu, C.C.et al. (2018) mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J. Biol. Chem. 293, 16464&#x2013;16478 10.1074/jbc.RA118.003991</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003991</ArticleId><ArticleId IdType="pmc">PMC6200946</ArticleId><ArticleId IdType="pubmed">30201609</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun, J.K., Choi, Y.K., Kim, J.H., Jeong, J.Y., Jeon, H.J., Kim, M.K.et al. (2017) A positive feedback loop between Sestrin2 and mTORC2 is required for the survival of glutamine-depleted lung cancer cells. Cell Rep. 20, 586&#x2013;599 10.1016/j.celrep.2017.06.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.06.066</ArticleId><ArticleId IdType="pubmed">28723563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao, R., Xiong, X., Liangpunsakul, S. and Dong, X.C. (2015) Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling. Diabetes 64, 1211&#x2013;1223 10.2337/db14-0539</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-0539</ArticleId><ArticleId IdType="pmc">PMC4375082</ArticleId><ArticleId IdType="pubmed">25377878</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, H.O., Hong, S.E., Park, J.A., Chang, Y.H., Hong, Y.J., Park, I.C.et al. (2016) Inhibition of JNK-mediated autophagy enhances NSCLC cell sensitivity to mTORC1/2 inhibitors. Sci. Rep. 6, 28945 10.1038/srep28945</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28945</ArticleId><ArticleId IdType="pmc">PMC4928093</ArticleId><ArticleId IdType="pubmed">27358039</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, D., Dai, W., Kutzler, L., Lacko, H.A., Jefferson, L.S., Dennis, M.D.et al. (2020) ATF4-mediated upregulation of REDD1 and Sestrin2 suppresses mTORC1 activity during prolonged leucine deprivation. J. Nutr. 150, 1022&#x2013;1030 10.1093/jn/nxz309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxz309</ArticleId><ArticleId IdType="pmc">PMC7198311</ArticleId><ArticleId IdType="pubmed">31875479</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Velde, L.A. and Murray, P.J. (2016) Proliferating helper T cells require rictor/mTORC2 complex to integrate signals from limiting environmental amino acids. J. Biol. Chem. 291, 25815&#x2013;25822 10.1074/jbc.C116.763623</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C116.763623</ArticleId><ArticleId IdType="pmc">PMC5207057</ArticleId><ArticleId IdType="pubmed">27799302</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L., Friedrichsen, H.J., Andrews, S., Picaud, S., Volpon, L., Ngeow, K.et al. (2018) A TFEB nuclear export signal integrates amino acid supply and glucose availability. Nat. Commun. 9, 2685 10.1038/s41467-018-04849-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04849-7</ArticleId><ArticleId IdType="pmc">PMC6041281</ArticleId><ArticleId IdType="pubmed">29992949</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S.et al. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214&#x2013;226 10.1016/j.molcel.2008.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.03.003</ArticleId><ArticleId IdType="pmc">PMC2674027</ArticleId><ArticleId IdType="pubmed">18439900</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington, L.S., Findlay, G.M. and Lamb, R.F. (2005) Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem. Sci. 30, 35&#x2013;42 10.1016/j.tibs.2004.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2004.11.003</ArticleId><ArticleId IdType="pubmed">15653324</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneque, A., Fortus, H., Zheng, J., Werlen, G. and Jacinto, E. (2023) The hexosamine biosynthesis pathway: regulation and function. Genes 14, 933 10.3390/genes14040933</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14040933</ArticleId><ArticleId IdType="pmc">PMC10138107</ArticleId><ArticleId IdType="pubmed">37107691</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron, A., Richard, D. and Laplante, M. (2015) The roles of mTOR complexes in lipid metabolism. Annu. Rev. Nutr. 35, 321&#x2013;348 10.1146/annurev-nutr-071714-034355</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-071714-034355</ArticleId><ArticleId IdType="pubmed">26185979</ArticleId></ArticleIdList></Reference><Reference><Citation>Szwed, A., Kim, E. and Jacinto, E. (2021) Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev. 101, 1371&#x2013;1426 10.1152/physrev.00026.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00026.2020</ArticleId><ArticleId IdType="pmc">PMC8424549</ArticleId><ArticleId IdType="pubmed">33599151</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorner, J. (2022) TOR complex 2 is a master regulator of plasma membrane homeostasis. Biochem. J. 479, 1917&#x2013;1940 10.1042/BCJ20220388</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220388</ArticleId><ArticleId IdType="pmc">PMC9555796</ArticleId><ArticleId IdType="pubmed">36149412</ArticleId></ArticleIdList></Reference><Reference><Citation>Guri, Y., Colombi, M., Dazert, E., Hindupur, S.K., Roszik, J., Moes, S.et al. (2017) mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell 32, 807&#x2013;823.e12 10.1016/j.ccell.2017.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2017.11.011</ArticleId><ArticleId IdType="pubmed">29232555</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon, D., Salloum, D., Bernfeld, E., Gorodetsky, E., Akselrod, A., Frias, M.A.et al. (2017) Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid. J. Biol. Chem. 292, 6303&#x2013;6311 10.1074/jbc.M116.772988</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.772988</ArticleId><ArticleId IdType="pmc">PMC5391759</ArticleId><ArticleId IdType="pubmed">28223357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon, M.S., Rosenberger, C.L., Wu, C., Truong, N., Sweedler, J.V. and Chen, J. (2015) Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid. Mol. Cell 58, 549&#x2013;556 10.1016/j.molcel.2015.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.03.028</ArticleId><ArticleId IdType="pmc">PMC4427522</ArticleId><ArticleId IdType="pubmed">25936805</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto, E. (2010) AGC kinases in mTOR signaling. Enzymes 27, 101&#x2013;128 10.1016/S1874-6047(10)27007-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1874-6047(10)27007-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessi, D.R., Pearce, L.R. and Garcia-Martinez, J.M. (2009) New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2, e27 10.1126/scisignal.267pe27</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.267pe27</ArticleId><ArticleId IdType="pubmed">19383978</ArticleId></ArticleIdList></Reference><Reference><Citation>Baffi, T.R., Lorden, G., Wozniak, J.M., Feichtner, A., Yeung, W., Kornev, A.P.et al. (2021) mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif. Sci. Signal. 14, eabe4509 10.1126/scisignal.abe4509</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abe4509</ArticleId><ArticleId IdType="pmc">PMC8208635</ArticleId><ArticleId IdType="pubmed">33850054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K.L. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919&#x2013;1931 10.1038/emboj.2008.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2008.119</ArticleId><ArticleId IdType="pmc">PMC2486275</ArticleId><ArticleId IdType="pubmed">18566587</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglioni, S., Benjamin, D., Walchli, M., Maier, T. and Hall, M.N. (2022) mTOR substrate phosphorylation in growth control. Cell 185, 1814&#x2013;1836 10.1016/j.cell.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.04.013</ArticleId><ArticleId IdType="pubmed">35580586</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning, B.D. and Toker, A. (2017) AKT/PKB signaling: navigating the network. Cell 169, 381&#x2013;405 10.1016/j.cell.2017.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5546324</ArticleId><ArticleId IdType="pubmed">28431241</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P.et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541&#x2013;6551 10.1002/j.1460-2075.1996.tb01045.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb01045.x</ArticleId><ArticleId IdType="pmc">PMC452479</ArticleId><ArticleId IdType="pubmed">8978681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarbassov, D.D., Guertin, D.A., Ali, S.M. and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098&#x2013;1101 10.1126/science.1106148</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1106148</ArticleId><ArticleId IdType="pubmed">15718470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hresko, R.C. and Mueckler, M. (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406&#x2013;40416 10.1074/jbc.M508361200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M508361200</ArticleId><ArticleId IdType="pubmed">16221682</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, J., Park, J., Cron, P., Hess, D. and Hemmings, B.A. (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279, 41189&#x2013;41196 10.1074/jbc.M406731200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406731200</ArticleId><ArticleId IdType="pubmed">15262962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami, Y., Nishimoto, H., Kitaura, J., Maeda-Yamamoto, M., Kato, R.M., Littman, D.R.et al. (2004) Protein kinase C &#x3b2;II regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J. Biol. Chem. 279, 47720&#x2013;47725 10.1074/jbc.M408797200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408797200</ArticleId><ArticleId IdType="pubmed">15364915</ArticleId></ArticleIdList></Reference><Reference><Citation>Toker, A. and Newton, A.C. (2000) Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275, 8271&#x2013;8274 10.1074/jbc.275.12.8271</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.12.8271</ArticleId><ArticleId IdType="pubmed">10722653</ArticleId></ArticleIdList></Reference><Reference><Citation>Troussard, A.A., Mawji, N.M., Ong, C., Mui, A., St-Arnaud, R. and Dedhar, S. (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J. Biol. Chem. 278, 22374&#x2013;22378 10.1074/jbc.M303083200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303083200</ArticleId><ArticleId IdType="pubmed">12686550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozulic, L., Surucu, B., Hynx, D. and Hemmings, B.A. (2008) PKB&#x3b1;/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell 30, 203&#x2013;213 10.1016/j.molcel.2008.02.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.02.024</ArticleId><ArticleId IdType="pubmed">18439899</ArticleId></ArticleIdList></Reference><Reference><Citation>Viniegra, J.G., Martinez, N., Modirassari, P., Losa, J.H., Parada Cobo, C., Lobo, V.J.et al. (2005) Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J. Biol. Chem. 280, 4029&#x2013;4036 10.1074/jbc.M410344200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410344200</ArticleId><ArticleId IdType="pubmed">15546863</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao, K., Kobayashi, S., Jaffer, Z.M., Huang, Y., Volden, P., Chernoff, J.et al. (2008) Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes. J. Mol. Cell. Cardiol. 44, 429&#x2013;434 10.1016/j.yjmcc.2007.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2007.10.016</ArticleId><ArticleId IdType="pmc">PMC2278035</ArticleId><ArticleId IdType="pubmed">18054038</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalle Pezze, P., Sonntag, A.G., Thien, A., Prentzell, M.T., Godel, M., Fischer, S.et al. (2012) A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci. Signal. 5, ra25 10.1126/scisignal.2002469</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2002469</ArticleId><ArticleId IdType="pubmed">22457331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, Q., Zhou, W., Wang, W., Dong, B., Han, D., Shen, T.et al. (2021) MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade. Sci. Adv. 7, eabi6439 10.1126/sciadv.abi6439</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abi6439</ArticleId><ArticleId IdType="pmc">PMC8589317</ArticleId><ArticleId IdType="pubmed">34767444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane, M.J., Coxon, P.Y., Powell, D.W., Webster, R., Klein, J.B., Pierce, W.et al. (2001) P38 kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276, 3517&#x2013;3523 10.1074/jbc.M005953200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M005953200</ArticleId><ArticleId IdType="pubmed">11042204</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Y., Fang, S.J., Zhu, L.J., Zhu, L.Q. and Zhou, X.Z. (2014) DNA-PKcs-SIN1 complexation mediates low-dose X-ray irradiation (LDI)-induced Akt activation and osteoblast differentiation. Biochem. Biophys. Res. Commun. 453, 362&#x2013;367 10.1016/j.bbrc.2014.09.088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.09.088</ArticleId><ArticleId IdType="pubmed">25264192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, H., Gu, Y., Qian, Y., Hu, B., Zhu, C., Wang, G.et al. (2014) DNA-PKcs is important for Akt activation and gemcitabine resistance in PANC-1 pancreatic cancer cells. Biochem. Biophys. Res. Commun. 452, 106&#x2013;111 10.1016/j.bbrc.2014.08.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.08.059</ArticleId><ArticleId IdType="pubmed">25152407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao, C.A., Ortiz-Vega, S., Sun, Y.Y., Chien, C.T., Chuang, J.H. and Lin, Y. (2017) Association of mSin1 with mTORC2 Ras and Akt reveals a crucial domain on mSin1 involved in Akt phosphorylation. Oncotarget 8, 63392&#x2013;63404 10.18632/oncotarget.18818</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.18818</ArticleId><ArticleId IdType="pmc">PMC5609931</ArticleId><ArticleId IdType="pubmed">28968999</ArticleId></ArticleIdList></Reference><Reference><Citation>He, J., Zhao, J., Quan, Y., Hou, X., Yang, M. and Dong, Z. (2021) Full activation of kinase protein kinase B by phosphoinositide-dependent protein kinase-1 and mammalian target of rapamycin complex 2 is required for early natural killer cell development and survival. Front. Immunol. 11, 617404 10.3389/fimmu.2020.617404</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.617404</ArticleId><ArticleId IdType="pmc">PMC7901528</ArticleId><ArticleId IdType="pubmed">33633735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, X., Lu, S., Nie, J., Hu, X., Luo, W., Wu, X.et al. (2014) Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice. Mol. Cell. Biol. 34, 1966&#x2013;1975 10.1128/MCB.00144-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00144-14</ArticleId><ArticleId IdType="pmc">PMC4019065</ArticleId><ArticleId IdType="pubmed">24662050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearney, A.L., Cooke, K.C., Norris, D.M., Zadoorian, A., Krycer, J.R., Fazakerley, D.J.et al. (2019) Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes. J. Biol. Chem. 294, 16729&#x2013;16739 10.1074/jbc.RA119.010036</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.010036</ArticleId><ArticleId IdType="pmc">PMC6851323</ArticleId><ArticleId IdType="pubmed">31548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzano, D., Fawal, M.A., Velazquez, J.V., Santiveri, C.M., Yang, J., Pastor, J.et al. (2015) Alternative activation mechanisms of protein kinase B trigger distinct downstream signaling responses. J. Biol. Chem. 290, 24975&#x2013;24985 10.1074/jbc.M115.651570</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.651570</ArticleId><ArticleId IdType="pmc">PMC4599004</ArticleId><ArticleId IdType="pubmed">26286748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, A., Lawrence, Jr, J.C., Jung, D.Y., Ko, H.J., Keller, S.R., Kim, J.K.et al. (2010) Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59, 1397&#x2013;1406 10.2337/db09-1061</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-1061</ArticleId><ArticleId IdType="pmc">PMC2874700</ArticleId><ArticleId IdType="pubmed">20332342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Z., Yao, Y., You, M., Liu, J., Guo, W., Qi, Z.et al. (2021) The kinase PDK1 is critical for promoting T follicular helper cell differentiation. eLife 10, e61406 10.7554/eLife.61406</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61406</ArticleId><ArticleId IdType="pmc">PMC7889074</ArticleId><ArticleId IdType="pubmed">33595435</ArticleId></ArticleIdList></Reference><Reference><Citation>Venigalla, R.K., McGuire, V.A., Clarke, R., Patterson-Kane, J.C., Najafov, A., Toth, R.et al. (2013) PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development. EMBO J. 32, 1008&#x2013;1022 10.1038/emboj.2013.40</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.40</ArticleId><ArticleId IdType="pmc">PMC3616287</ArticleId><ArticleId IdType="pubmed">23463102</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, M.R., Arthur, J.S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P.et al. (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439&#x2013;448 10.1016/S0960-9822(00)00441-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00441-3</ArticleId><ArticleId IdType="pubmed">10801415</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y.T., Ouyang, W., Lazorchak, A.S., Liu, D., Shen, H.M. and Su, B. (2011) mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif. J. Biol. Chem. 286, 14190&#x2013;14198 10.1074/jbc.M111.219923</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.219923</ArticleId><ArticleId IdType="pmc">PMC3077620</ArticleId><ArticleId IdType="pubmed">21321111</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F.et al. (2012) Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725&#x2013;738 10.1016/j.cmet.2012.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.03.015</ArticleId><ArticleId IdType="pubmed">22521878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cybulski, N., Polak, P., Auwerx, J., Ruegg, M.A. and Hall, M.N. (2009) mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc. Natl Acad. Sci. U.S.A. 106, 9902&#x2013;9907 10.1073/pnas.0811321106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811321106</ArticleId><ArticleId IdType="pmc">PMC2700987</ArticleId><ArticleId IdType="pubmed">19497867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, P.C., Oh, W.J., Wu, C.C., Moloughney, J., Ruegg, M.A., Hall, M.N.et al. (2014) Mammalian target of rapamycin complex 2 modulates &#x3b1;&#x3b2;TCR processing and surface expression during thymocyte development. J. Immunol. 193, 1162&#x2013;1170 10.4049/jimmunol.1303162</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303162</ArticleId><ArticleId IdType="pmc">PMC4108500</ArticleId><ArticleId IdType="pubmed">24981454</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, P., Begley, M., Michowski, W., Inuzuka, H., Ginzberg, M., Gao, D.et al. (2014) Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508, 541&#x2013;545 10.1038/nature13079</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13079</ArticleId><ArticleId IdType="pmc">PMC4076493</ArticleId><ArticleId IdType="pubmed">24670654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, T., Deak, M., Morrice, N. and Cohen, P. (1999) Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem. J. 344 (Pt 1), 189&#x2013;197 10.1042/bj3440189</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3440189</ArticleId><ArticleId IdType="pmc">PMC1220630</ArticleId><ArticleId IdType="pubmed">10548550</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, C.H., Moon, J., Park, M., Cheng, H., Lee, J. and Chang, J.S. (2021) Protein kinase SGK2 is induced by the &#x3b2;3 adrenergic receptor-cAMP-PKA-PGC-1&#x3b1;/NT-PGC-1&#x3b1; axis but dispensable for brown/beige adipose tissue thermogenesis. Front. Physiol. 12, 780312 10.3389/fphys.2021.780312</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.780312</ArticleId><ArticleId IdType="pmc">PMC8657153</ArticleId><ArticleId IdType="pubmed">34899399</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, D., Yang, X. and Songyang, Z. (2000) Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr. Biol. 10, 1233&#x2013;1236 10.1016/S0960-9822(00)00733-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00733-8</ArticleId><ArticleId IdType="pubmed">11050396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao, A.C., McCormick, J.A., Li, H., Siu, J., Govaerts, C., Bhalla, V.et al. (2007) NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions. Am. J. Physiol. Renal Physiol. 292, F1741&#x2013;F1750 10.1152/ajprenal.00027.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00027.2007</ArticleId><ArticleId IdType="pubmed">17356130</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, W., Chen, Y., Xu, B.E., Juang, Y.C., Stippec, S., Zhao, Y.et al. (2009) Regulation of a third conserved phosphorylation site in SGK1. J. Biol. Chem. 284, 3453&#x2013;3460 10.1074/jbc.M807502200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M807502200</ArticleId><ArticleId IdType="pmc">PMC2635031</ArticleId><ArticleId IdType="pubmed">19068477</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasser, J.A., Inuzuka, H., Lau, A.W., Wei, W., Beroukhim, R. and Toker, A. (2014) SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol. Cell 56, 595&#x2013;607 10.1016/j.molcel.2014.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.09.023</ArticleId><ArticleId IdType="pmc">PMC4255362</ArticleId><ArticleId IdType="pubmed">25458846</ArticleId></ArticleIdList></Reference><Reference><Citation>Bago, R., Sommer, E., Castel, P., Crafter, C., Bailey, F.P., Shpiro, N.et al. (2016) The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth. EMBO J. 35, 1902&#x2013;1922 10.15252/embj.201693929</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201693929</ArticleId><ArticleId IdType="pmc">PMC5007552</ArticleId><ArticleId IdType="pubmed">27481935</ArticleId></ArticleIdList></Reference><Reference><Citation>He, P., Lee, S.J., Lin, S., Seidler, U., Lang, F., Fejes-Toth, G.et al. (2011) Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids. Mol. Biol. Cell 22, 3812&#x2013;3825 10.1091/mbc.e11-04-0328</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-04-0328</ArticleId><ArticleId IdType="pmc">PMC3192861</ArticleId><ArticleId IdType="pubmed">21865597</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich, B., Feng, Y., Cohen, P., Risler, T., Vandewalle, A., Broer, S.et al. (2003) The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel &#x3b1;,&#x3b2;,&#x3b3;-ENaC. Pflugers Arch. 445, 693&#x2013;696 10.1007/s00424-002-0993-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-002-0993-8</ArticleId><ArticleId IdType="pubmed">12632189</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao, A.C., Bhargava, A., Di Sole, F., Quigley, R., Shao, X., Wang, J.et al. (2010) Expression and role of serum and glucocorticoid-regulated kinase 2 in the regulation of Na+/H+ exchanger 3 in the mammalian kidney. Am. J. Physiol. Renal Physiol. 299, F1496&#x2013;F1506 10.1152/ajprenal.00075.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00075.2010</ArticleId><ArticleId IdType="pmc">PMC3006302</ArticleId><ArticleId IdType="pubmed">20926631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen, M.V., Saha, B., Jensen, I.S., Wu, P., Ayasse, N., Gleason, C.E.et al. (2019) Potassium acts through mTOR to regulate its own secretion. JCI Insight 5, e126910 10.1172/jci.insight.126910</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126910</ArticleId><ArticleId IdType="pmc">PMC6629116</ArticleId><ArticleId IdType="pubmed">31013253</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha, B., Shabbir, W., Takagi, E., Duan, X.P., Almeida Leite Dellova, D.C., Demko, J.et al. (2023) Potassium activates mTORC2-dependent SGK1 phosphorylation to stimulate ENaC: role in rapid renal responses to dietary potassium. J. Am. Soc. Nephrol. 34, 1019&#x2013;1038 10.1681/ASN.0000000000000109</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.0000000000000109</ArticleId><ArticleId IdType="pmc">PMC10278851</ArticleId><ArticleId IdType="pubmed">36890646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, W.Y., Lin, C.L., Chuang, J.H., Chiu, F.Y., Sun, Y.Y., Liang, M.C.et al. (2017) Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle differentiation. Sci. Rep. 7, 41159 10.1038/srep41159</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41159</ArticleId><ArticleId IdType="pmc">PMC5247691</ArticleId><ArticleId IdType="pubmed">28106162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, D., Wan, L., Inuzuka, H., Berg, A.H., Tseng, A., Zhai, B.et al. (2010) Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol. Cell 39, 797&#x2013;808 10.1016/j.molcel.2010.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.08.016</ArticleId><ArticleId IdType="pmc">PMC2939073</ArticleId><ArticleId IdType="pubmed">20832730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, W., Zheng, H. and Canessa, C.M. (2023) Phosphatases maintain low catalytic activity of SGK1: DNA damage resets the balance in favor of phosphorylation. J. Biol. Chem. 299, 104941 10.1016/j.jbc.2023.104941</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.104941</ArticleId><ArticleId IdType="pmc">PMC10372406</ArticleId><ArticleId IdType="pubmed">37343701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer, E.M., Dry, H., Cross, D., Guichard, S., Davies, B.R. and Alessi, D.R. (2013) Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors. Biochem. J. 452, 499&#x2013;508 10.1042/BJ20130342</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20130342</ArticleId><ArticleId IdType="pmc">PMC3671793</ArticleId><ArticleId IdType="pubmed">23581296</ArticleId></ArticleIdList></Reference><Reference><Citation>Caohuy, H., Yang, Q., Eudy, Y., Ha, T.A., Xu, A.E., Glover, M.et al. (2014) Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of &#x394;F508-cystic fibrosis transmembrane conductance regulator (&#x394;F508-CFTR). J. Biol. Chem. 289, 35953&#x2013;35968 10.1074/jbc.M114.598649</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.598649</ArticleId><ArticleId IdType="pmc">PMC4276863</ArticleId><ArticleId IdType="pubmed">25384981</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen, J.R., Persson, K.W., Meister, J., Carl, C.S., Raun, S.H., Andersen, N.R.et al. (2022) Exercise increases phosphorylation of the putative mTORC2 activity readout NDRG1 in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 322, E63&#x2013;E73 10.1152/ajpendo.00389.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00389.2021</ArticleId><ArticleId IdType="pmc">PMC8759970</ArticleId><ArticleId IdType="pubmed">34866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, K., El-Merahbi, R., Loeffler, M., Mayer, A.E. and Sumara, G. (2017) Ndrg1 promotes adipocyte differentiation and sustains their function. Sci. Rep. 7, 7191 10.1038/s41598-017-07497-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07497-x</ArticleId><ArticleId IdType="pmc">PMC5543145</ArticleId><ArticleId IdType="pubmed">28775290</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, M.N., Krzystanek, K., Petersen, F., Bomholtz, S.H., Olesen, S.P., Abriel, H.et al. (2013) A phosphoinositide 3-kinase (PI3K)-serum- and glucocorticoid-inducible kinase 1 (SGK1) pathway promotes Kv7.1 channel surface expression by inhibiting Nedd4-2 protein. J. Biol. Chem. 288, 36841&#x2013;36854 10.1074/jbc.M113.525931</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.525931</ArticleId><ArticleId IdType="pmc">PMC3873543</ArticleId><ArticleId IdType="pubmed">24214981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, I.H., Dinudom, A., Sanchez-Perez, A., Kumar, S. and Cook, D.I. (2007) Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2. J. Biol. Chem. 282, 29866&#x2013;29873 10.1074/jbc.M701923200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M701923200</ArticleId><ArticleId IdType="pubmed">17715136</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikamp, E.B., Patel, C.H., Collins, S., Waickman, A., Oh, M.H., Sun, I.H.et al. (2014) The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat. Immunol. 15, 457&#x2013;464 10.1038/ni.2867</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2867</ArticleId><ArticleId IdType="pmc">PMC4267697</ArticleId><ArticleId IdType="pubmed">24705297</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton, A.C. (2010) Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 298, E395&#x2013;E402 10.1152/ajpendo.00477.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00477.2009</ArticleId><ArticleId IdType="pmc">PMC2838521</ArticleId><ArticleId IdType="pubmed">19934406</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg, S.F. (2008) Structural basis of protein kinase C isoform function. Physiol. Rev. 88, 1341&#x2013;1378 10.1152/physrev.00034.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00034.2007</ArticleId><ArticleId IdType="pmc">PMC2899688</ArticleId><ArticleId IdType="pubmed">18923184</ArticleId></ArticleIdList></Reference><Reference><Citation>Amemiya, Y., Maki, M., Shibata, H. and Takahara, T. (2023) New insights into the regulation of mTOR signaling via Ca2+-binding proteins. Int. J. Mol. Sci. 24, 3923 10.3390/ijms24043923</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043923</ArticleId><ArticleId IdType="pmc">PMC9959742</ArticleId><ArticleId IdType="pubmed">36835331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Bautista, S., Marin-Vicente, C., Gomez-Fernandez, J.C. and Corbalan-Garcia, S. (2006) The C2 domain of PKC&#x3b1; is a Ca2+-dependent PtdIns(4,5)P2 sensing domain: a new insight into an old pathway. J. Mol. Biol. 362, 901&#x2013;914 10.1016/j.jmb.2006.07.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.07.093</ArticleId><ArticleId IdType="pubmed">16949603</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, J.H., Murray, D., Leslie, C.C. and Falke, J.J. (2006) Specific translocation of protein kinase C&#x3b1; to the plasma membrane requires both Ca2+ and PIP2 recognition by its C2 domain. Mol. Biol. Cell 17, 56&#x2013;66 10.1091/mbc.e05-06-0499</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-06-0499</ArticleId><ArticleId IdType="pmc">PMC1345646</ArticleId><ArticleId IdType="pubmed">16236797</ArticleId></ArticleIdList></Reference><Reference><Citation>Min, X., Wang, S., Zhang, X., Sun, N. and Kim, K.M. (2023) PKC&#x3b2;II activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination. Life Sci. Alliance 6, e202201748 10.26508/lsa.202201748</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202201748</ArticleId><ArticleId IdType="pmc">PMC9887771</ArticleId><ArticleId IdType="pubmed">36717249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee, E., Chaudhuri, R.D. and Sarkar, S. (2019) Cardiomyocyte targeted overexpression of IGF1 during detraining restores compromised cardiac condition via mTORC2 mediated switching of PKC&#x3b4; to PKC&#x3b1;. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2736&#x2013;2752 10.1016/j.bbadis.2019.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.07.003</ArticleId><ArticleId IdType="pubmed">31299218</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcantara, D., Elmslie, F., Tetreault, M., Bareke, E., Hartley, T., Care4Rare Consortium et al. (2017) SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cvarepsilon) impairing TORC2-dependent AKT activation. Hum. Mol. Genet. 26, 3713&#x2013;3721 10.1093/hmg/ddx256</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx256</ArticleId><ArticleId IdType="pubmed">28934384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N.et al. (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32, 743&#x2013;753 10.1016/j.immuni.2010.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.06.002</ArticleId><ArticleId IdType="pmc">PMC2911434</ArticleId><ArticleId IdType="pubmed">20620941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Y., Wang, P., Zhang, L., Bai, G., Yang, C., Wang, Y.et al. (2019) Superhero Rictor promotes cellular differentiation of mouse embryonic stem cells. Cell Death Differ. 26, 958&#x2013;968 10.1038/s41418-018-0177-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0177-5</ArticleId><ArticleId IdType="pmc">PMC6461888</ArticleId><ArticleId IdType="pubmed">30154443</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X. and Gao, T. (2014) mTORC2 phosphorylates protein kinase C&#x3b6; to regulate its stability and activity. EMBO Rep. 15, 191&#x2013;198 10.1002/embr.201338119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/embr.201338119</ArticleId><ArticleId IdType="pmc">PMC3989865</ArticleId><ArticleId IdType="pubmed">24375676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias, I.S. and Newton, A.C. (2016) Protein scaffolds control localized protein kinase C&#x3b6; activity. J. Biol. Chem. 291, 13809&#x2013;13822 10.1074/jbc.M116.729483</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.729483</ArticleId><ArticleId IdType="pmc">PMC4919463</ArticleId><ArticleId IdType="pubmed">27143478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallroth, A., Koch, P.A., Marat, A.L., Krause, E. and Haucke, V. (2019) Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1. Nat. Cell Biol. 21, 1093&#x2013;1101 10.1038/s41556-019-0377-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0377-3</ArticleId><ArticleId IdType="pubmed">31451768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S.J., DeStefano, M.A., Oh, W.J., Wu, C.C., Vega-Cotto, N.M., Finlan, M.et al. (2012) mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Mol. Cell 48, 875&#x2013;887 10.1016/j.molcel.2012.09.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.09.029</ArticleId><ArticleId IdType="pmc">PMC3534931</ArticleId><ArticleId IdType="pubmed">23142081</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, N., Christiansen, J., Nielsen, F.C. and Avruch, J. (2013) mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts. Genes Dev. 27, 301&#x2013;312 10.1101/gad.209130.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.209130.112</ArticleId><ArticleId IdType="pmc">PMC3576515</ArticleId><ArticleId IdType="pubmed">23388827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin, Y., Hua, H., Li, M., Liu, S., Kong, Q., Shao, T.et al. (2016) mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Cell Res. 26, 46&#x2013;65 10.1038/cr.2015.133</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2015.133</ArticleId><ArticleId IdType="pmc">PMC4816127</ArticleId><ArticleId IdType="pubmed">26584640</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder, P.K., Febbo, P.G., Bikoff, R., Berger, R., Xue, Q., McMahon, L.M.et al. (2004) mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10, 594&#x2013;601 10.1038/nm1052</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1052</ArticleId><ArticleId IdType="pubmed">15156201</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui, K., Tanaka, K., Akhavan, D., Babic, I., Gini, B., Matsutani, T.et al. (2013) mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 18, 726&#x2013;739 10.1016/j.cmet.2013.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.09.013</ArticleId><ArticleId IdType="pmc">PMC3840163</ArticleId><ArticleId IdType="pubmed">24140020</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthel, A., Okino, S.T., Liao, J., Nakatani, K., Li, J., Whitlock, Jr, J.P.et al. (1999) Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 274, 20281&#x2013;20286 10.1074/jbc.274.29.20281</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.29.20281</ArticleId><ArticleId IdType="pubmed">10400647</ArticleId></ArticleIdList></Reference><Reference><Citation>Deprez, J., Vertommen, D., Alessi, D.R., Hue, L. and Rider, M.H. (1997) Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272, 17269&#x2013;17275 10.1074/jbc.272.28.17269</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.28.17269</ArticleId><ArticleId IdType="pubmed">9211863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R.B. and Hay, N. (2001) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15, 1406&#x2013;1418 10.1101/gad.889901</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.889901</ArticleId><ArticleId IdType="pmc">PMC312709</ArticleId><ArticleId IdType="pubmed">11390360</ArticleId></ArticleIdList></Reference><Reference><Citation>Robey, R.B. and Hay, N. (2009) Is Akt the &#x201c;Warburg kinase&#x201d;?&#x2014;Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 19, 25&#x2013;31 10.1016/j.semcancer.2008.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2008.11.010</ArticleId><ArticleId IdType="pmc">PMC2814453</ArticleId><ArticleId IdType="pubmed">19130886</ArticleId></ArticleIdList></Reference><Reference><Citation>Elstrom, R.L., Bauer, D.E., Buzzai, M., Karnauskas, R., Harris, M.H., Plas, D.R.et al. (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892&#x2013;3899 10.1158/0008-5472.CAN-03-2904</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-03-2904</ArticleId><ArticleId IdType="pubmed">15172999</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirumurthi, U., Shen, J., Xia, W., LaBaff, A.M., Wei, Y., Li, C.W.et al. (2014) MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Sci. Signal. 7, ra71 10.1126/scisignal.2005076</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2005076</ArticleId><ArticleId IdType="pmc">PMC4161976</ArticleId><ArticleId IdType="pubmed">25074979</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombi, M., Molle, K.D., Benjamin, D., Rattenbacher-Kiser, K., Schaefer, C., Betz, C.et al. (2011) Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. Oncogene 30, 1551&#x2013;1565 10.1038/onc.2010.539</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2010.539</ArticleId><ArticleId IdType="pubmed">21170086</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C., Li, Y., He, L., Agarwal, A.R., Zeng, N., Cadenas, E.et al. (2013) PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes. Free Radic. Biol. Med. 60, 29&#x2013;40 10.1016/j.freeradbiomed.2013.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.01.013</ArticleId><ArticleId IdType="pmc">PMC3654039</ArticleId><ArticleId IdType="pubmed">23376468</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita, M., Gravel, S.P., Chenard, V., Sikstrom, K., Zheng, L., Alain, T.et al. (2013) mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 18, 698&#x2013;711 10.1016/j.cmet.2013.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.10.001</ArticleId><ArticleId IdType="pubmed">24206664</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieke, S.M., Phillips, D., McCoy, Jr, J.P., Aponte, A.M., Shen, R.F., Balaban, R.S.et al. (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 281, 27643&#x2013;27652 10.1074/jbc.M603536200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M603536200</ArticleId><ArticleId IdType="pubmed">16847060</ArticleId></ArticleIdList></Reference><Reference><Citation>Inigo, M., Deja, S. and Burgess, S.C. (2021) Ins and outs of the TCA cycle: the central role of anaplerosis. Annu. Rev. Nutr. 41, 19&#x2013;47 10.1146/annurev-nutr-120420-025558</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-120420-025558</ArticleId><ArticleId IdType="pubmed">34270333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang, C.V. (2016) A time for MYC: metabolism and therapy. Cold Spring Harb. Symp. Quant. Biol. 81, 79&#x2013;83 10.1101/sqb.2016.81.031153</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2016.81.031153</ArticleId><ArticleId IdType="pubmed">28174256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Y., Albuquerque, C.P., Braas, D., Zhang, W., Villa, G.R., Bi, J.et al. (2017) mTORC2 regulates amino acid metabolism in cancer by phosphorylation of the cystine-glutamate antiporter xCT. Mol. Cell 67, 128&#x2013;138.e7 10.1016/j.molcel.2017.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.05.030</ArticleId><ArticleId IdType="pmc">PMC5521991</ArticleId><ArticleId IdType="pubmed">28648777</ArticleId></ArticleIdList></Reference><Reference><Citation>Werlen, G., Li, M.L., Tottone, L., da Silva-Diz, V., Su, X., Herranz, D.et al. (2022) Dietary glucosamine overcomes the defects in &#x3b1;&#x3b2;-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis. Nat. Commun. 13, 7404 10.1038/s41467-022-35014-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35014-w</ArticleId><ArticleId IdType="pmc">PMC9715696</ArticleId><ArticleId IdType="pubmed">36456551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, J., Huang, Y., Zhang, X., Yu, Y., Wu, S., Jiao, J.et al. (2020) TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism. Nat. Commun. 11, 1880 10.1038/s41467-020-15819-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15819-3</ArticleId><ArticleId IdType="pmc">PMC7170963</ArticleId><ArticleId IdType="pubmed">32312982</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha, A., Connelly, S., Jiang, J., Zhuang, S., Amador, D.T., Phan, T.et al. (2014) Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis. Mol. Cell 55, 264&#x2013;276 10.1016/j.molcel.2014.05.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.05.028</ArticleId><ArticleId IdType="pmc">PMC4104231</ArticleId><ArticleId IdType="pubmed">24981175</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, F., Gai, X., Wu, Y., Zhang, B., Wu, X., Cheng, R.et al. (2022) Oncogenic &#x3b2;-catenin stimulation of AKT2&#x2013;CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc. Natl Acad. Sci. U.S.A. 119, e2202157119 10.1073/pnas.2202157119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2202157119</ArticleId><ArticleId IdType="pmc">PMC9522414</ArticleId><ArticleId IdType="pubmed">36122209</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, L., Chen, C., Guo, Y., Zhang, F., Mi, J., Feng, Q.et al. (2021) mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer. Neoplasia 23, 643&#x2013;652 10.1016/j.neo.2021.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8215139</ArticleId><ArticleId IdType="pubmed">34126361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Qian, J., He, Q., Zhao, H., Toral-Barza, L., Shi, C.et al. (2016) mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer. Oncotarget 7, 25224&#x2013;25240 10.18632/oncotarget.8279</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8279</ArticleId><ArticleId IdType="pmc">PMC5041899</ArticleId><ArticleId IdType="pubmed">27015560</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez Calejman, C., Trefely, S., Entwisle, S.W., Luciano, A., Jung, S.M., Hsiao, W.et al. (2020) mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. Nat. Commun. 11, 575 10.1038/s41467-020-14430-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14430-w</ArticleId><ArticleId IdType="pmc">PMC6989638</ArticleId><ArticleId IdType="pubmed">31996678</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick, D.C., Hers, I., Heesom, K.J., Moule, S.K. and Tavare, J.M. (2002) The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J. Biol. Chem. 277, 33895&#x2013;33900 10.1074/jbc.M204681200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M204681200</ArticleId><ArticleId IdType="pubmed">12107176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S., Oh, Y.T., Yue, P., Khuri, F.R. and Sun, S.Y. (2016) Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Oncogene 35, 642&#x2013;650 10.1038/onc.2015.123</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2015.123</ArticleId><ArticleId IdType="pmc">PMC4615269</ArticleId><ArticleId IdType="pubmed">25893295</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, M., Pino, E., Wu, L., Kacergis, M. and Soukas, A.A. (2012) Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J. Biol. Chem. 287, 29579&#x2013;29588 10.1074/jbc.M112.386854</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.386854</ArticleId><ArticleId IdType="pmc">PMC3436168</ArticleId><ArticleId IdType="pubmed">22773877</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifeh-Soltani, A., McKleroy, W., Sakuma, S., Cheung, Y.Y., Tharp, K., Qiu, Y.et al. (2014) Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids. Nat. Med. 20, 175&#x2013;183 10.1038/nm.3450</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3450</ArticleId><ArticleId IdType="pmc">PMC4273653</ArticleId><ArticleId IdType="pubmed">24441829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, Y., Wallace, M., Sanchez-Gurmaches, J., Hsiao, W.Y., Li, H., Lee, P.L.et al. (2016) Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat. Commun. 7, 11365 10.1038/ncomms11365</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11365</ArticleId><ArticleId IdType="pmc">PMC4844681</ArticleId><ArticleId IdType="pubmed">27098609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung, S.M., Hung, C.M., Hildebrand, S.R., Sanchez-Gurmaches, J., Martinez-Pastor, B., Gengatharan, J.M.et al. (2019) Non-canonical mTORC2 signaling regulates brown adipocyte lipid catabolism through SIRT6-FoxO1. Mol. Cell 75, 807&#x2013;822.e8 10.1016/j.molcel.2019.07.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.07.023</ArticleId><ArticleId IdType="pmc">PMC7388077</ArticleId><ArticleId IdType="pubmed">31442424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, L., Lei, B., Wang, L., Chang, C., Yang, H., Liu, J.et al. (2019) Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression. Onco Targets Ther. 12, 5835&#x2013;5848 10.2147/OTT.S207211</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S207211</ArticleId><ArticleId IdType="pmc">PMC6646854</ArticleId><ArticleId IdType="pubmed">31410027</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair, D., Dufort, F.J. and Chiles, T.C. (2012) Protein kinase C&#x3b2; is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. Biochem. J. 448, 165&#x2013;169 10.1042/BJ20121225</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20121225</ArticleId><ArticleId IdType="pubmed">22994860</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyaraj, S., Boehmer, C., Lang, F. and Palmada, M. (2007) Role of SGK1 kinase in regulating glucose transport via glucose transporter GLUT4. Biochem. Biophys. Res. Commun. 356, 629&#x2013;635 10.1016/j.bbrc.2007.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.03.029</ArticleId><ArticleId IdType="pubmed">17382906</ArticleId></ArticleIdList></Reference><Reference><Citation>Santo-Domingo, J., Chareyron, I., Dayon, L., Nunez Galindo, A., Cominetti, O., Pilar Giner Gimenez, M.et al. (2017) Coordinated activation of mitochondrial respiration and exocytosis mediated by PKC signaling in pancreatic &#x3b2; cells. FASEB J. 31, 1028&#x2013;1045 10.1096/fj.201600837R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600837R</ArticleId><ArticleId IdType="pubmed">27927723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahato, B., Home, P., Rajendran, G., Paul, A., Saha, B., Ganguly, A.et al. (2014) Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-&#x3bb;/&#x3b9;: a novel mode of balancing pluripotency. Stem Cells 32, 2880&#x2013;2892 10.1002/stem.1817</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1817</ArticleId><ArticleId IdType="pmc">PMC4198455</ArticleId><ArticleId IdType="pubmed">25142417</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel, V.T. and Shulman, G.I. (2018) Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 27, 22&#x2013;41 10.1016/j.cmet.2017.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.08.002</ArticleId><ArticleId IdType="pmc">PMC5762395</ArticleId><ArticleId IdType="pubmed">28867301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakoda, H., Gotoh, Y., Katagiri, H., Kurokawa, M., Ono, H., Onishi, Y.et al. (2003) Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J. Biol. Chem. 278, 25802&#x2013;25807 10.1074/jbc.M301127200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301127200</ArticleId><ArticleId IdType="pubmed">12734207</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel, V.T., Liu, Z.X., Wang, A., Beddow, S.A., Geisler, J.G., Kahn, M.et al. (2007) Inhibition of protein kinase C&#x3b5; prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117, 739&#x2013;745 10.1172/JCI30400</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30400</ArticleId><ArticleId IdType="pmc">PMC1797607</ArticleId><ArticleId IdType="pubmed">17318260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz-Peiffer, C. (2013) The tail wagging the dog &#x2013; regulation of lipid metabolism by protein kinase C. FEBS J. 280, 5371&#x2013;5383 10.1111/febs.12285</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12285</ArticleId><ArticleId IdType="pubmed">23587021</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulhati, P., Bowen, K.A., Liu, J., Stevens, P.D., Rychahou, P.G., Chen, M.et al. (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71, 3246&#x2013;3256 10.1158/0008-5472.CAN-10-4058</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-4058</ArticleId><ArticleId IdType="pmc">PMC3085654</ArticleId><ArticleId IdType="pubmed">21430067</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Y., Schoeps, B., Yao, D., Zhang, Z., Schuck, K., Tissen, V.et al. (2021) mTORC1 and mTORC2 converge on the Arp2/3 complex to promote Kras(G12D)-induced acinar-to-ductal metaplasia and early pancreatic carcinogenesis. Gastroenterology 160, 1755&#x2013;1770.e17 10.1053/j.gastro.2020.12.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.12.061</ArticleId><ArticleId IdType="pubmed">33388318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, X., Feng, M., Yang, H., Liu, H., Guo, H., Gao, X.et al. (2020) Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in hepatocellular carcinoma. Int. J. Biol. Sci. 16, 2835&#x2013;2852 10.7150/ijbs.46285</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.46285</ArticleId><ArticleId IdType="pmc">PMC7545703</ArticleId><ArticleId IdType="pubmed">33061800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chantaravisoot, N., Wongkongkathep, P., Loo, J.A., Mischel, P.S. and Tamanoi, F. (2015) Significance of filamin A in mTORC2 function in glioblastoma. Mol. Cancer 14, 127 10.1186/s12943-015-0396-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-015-0396-z</ArticleId><ArticleId IdType="pmc">PMC4489161</ArticleId><ArticleId IdType="pubmed">26134617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, T., Ishii, J., Ota, Y., Sasaki, E., Shibagaki, Y. and Hattori, S. (2016) Mammalian target of rapamycin (mTOR) complex 2 regulates filamin A-dependent focal adhesion dynamics and cell migration. Genes Cells 21, 579&#x2013;593 10.1111/gtc.12366</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12366</ArticleId><ArticleId IdType="pubmed">27059097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chantaravisoot, N., Wongkongkathep, P., Kalpongnukul, N., Pacharakullanon, N., Kaewsapsak, P., Ariyachet, C.et al. (2023) mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin. Sci. Rep. 13, 7037 10.1038/s41598-023-33872-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33872-y</ArticleId><ArticleId IdType="pmc">PMC10148843</ArticleId><ArticleId IdType="pubmed">37120454</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Lu, Y., Li, A., Celiku, O., Han, S., Qian, M.et al. (2020) mTORC2/Rac1 pathway predisposes cancer aggressiveness in IDH1-mutated glioma. Cancers 12, 787 10.3390/cancers12040787</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12040787</ArticleId><ArticleId IdType="pmc">PMC7226122</ArticleId><ArticleId IdType="pubmed">32224866</ArticleId></ArticleIdList></Reference><Reference><Citation>Diz-Munoz, A., Thurley, K., Chintamen, S., Altschuler, S.J., Wu, L.F., Fletcher, D.A.et al. (2016) Membrane tension acts through PLD2 and mTORC2 to limit actin network assembly during neutrophil migration. PLoS Biol. 14, e1002474 10.1371/journal.pbio.1002474</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002474</ArticleId><ArticleId IdType="pmc">PMC4900667</ArticleId><ArticleId IdType="pubmed">27280401</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha, S., Town, J.P. and Weiner, O.D. (2023) Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration. Mol. Biol. Cell 34, ar35 10.1091/mbc.E22-05-0191</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E22-05-0191</ArticleId><ArticleId IdType="pmc">PMC10162419</ArticleId><ArticleId IdType="pubmed">36857159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono, Y., Matsuzawa, K. and Ikenouchi, J. (2022) mTORC2 suppresses cell death induced by hypo-osmotic stress by promoting sphingomyelin transport. J. Cell Biol. 221, e202106160 10.1083/jcb.202106160</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202106160</ArticleId><ArticleId IdType="pmc">PMC8952684</ArticleId><ArticleId IdType="pubmed">35319770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta, S., Lorente-Rodriguez, A., Earnest, S., Stippec, S., Guo, X., Trudgian, D.C.et al. (2013) Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals. Proc. Natl Acad. Sci. U.S.A. 110, 18826&#x2013;18831 10.1073/pnas.1318676110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318676110</ArticleId><ArticleId IdType="pmc">PMC3839713</ArticleId><ArticleId IdType="pubmed">24191005</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias, E., Koga, H., Diaz, A., Mocholi, E., Patel, B. and Cuervo, A.M. (2015) Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy. Mol. Cell 59, 270&#x2013;284 10.1016/j.molcel.2015.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.05.030</ArticleId><ArticleId IdType="pmc">PMC4506737</ArticleId><ArticleId IdType="pubmed">26118642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, R.C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G.et al. (2012) Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338, 956&#x2013;959 10.1126/science.1225967</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1225967</ArticleId><ArticleId IdType="pmc">PMC3507442</ArticleId><ArticleId IdType="pubmed">23112296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuleger, T., Heinzelbecker, J., Takacs, Z., Hunter, C., Voelkl, J., Lang, F.et al. (2018) SGK1 inhibits autophagy in murine muscle tissue. Oxid. Med. Cell. Longev. 2018, 4043726 10.1155/2018/4043726</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4043726</ArticleId><ArticleId IdType="pmc">PMC5937381</ArticleId><ArticleId IdType="pubmed">29849891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzuglia, V., Lorenzon, I., Pellarin, I., Sonego, M., Dall'Acqua, A., D'Andrea, S.et al. (2020) Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells. Oncogene 39, 6370&#x2013;6386 10.1038/s41388-020-01433-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-020-01433-6</ArticleId><ArticleId IdType="pmc">PMC7529585</ArticleId><ArticleId IdType="pubmed">32848212</ArticleId></ArticleIdList></Reference><Reference><Citation>Renna, M., Bento, C.F., Fleming, A., Menzies, F.M., Siddiqi, F.H., Ravikumar, B.et al. (2013) IGF-1 receptor antagonism inhibits autophagy. Hum. Mol. Genet. 22, 4528&#x2013;4544 10.1093/hmg/ddt300</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt300</ArticleId><ArticleId IdType="pmc">PMC3889807</ArticleId><ArticleId IdType="pubmed">23804751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Y., Yoon, S.O., Poulogiannis, G., Yang, Q., Ma, X.M., Villen, J.et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322&#x2013;1326 10.1126/science.1199484</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1199484</ArticleId><ArticleId IdType="pmc">PMC3195509</ArticleId><ArticleId IdType="pubmed">21659605</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H.et al. (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213&#x2013;223 10.1083/jcb.200403069</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200403069</ArticleId><ArticleId IdType="pmc">PMC2172316</ArticleId><ArticleId IdType="pubmed">15249583</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, O.J., Wang, Z. and Hunter, T. (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650&#x2013;1656 10.1016/j.cub.2004.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2004.08.026</ArticleId><ArticleId IdType="pubmed">15380067</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly, K.E., Rojo, F., She, Q.B., Solit, D., Mills, G.B., Smith, D.et al. (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 66, 1500&#x2013;1508 10.1158/0008-5472.CAN-05-2925</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-2925</ArticleId><ArticleId IdType="pmc">PMC3193604</ArticleId><ArticleId IdType="pubmed">16452206</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalis, V., Caval-Holme, F. and Bateup, H.S. (2022) Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex. Nat. Commun. 13, 4665 10.1038/s41467-022-31961-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31961-6</ArticleId><ArticleId IdType="pmc">PMC9363483</ArticleId><ArticleId IdType="pubmed">35945201</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuleux, M., Klopfenstein, M., Stephan, C., Doughty, C.A., Barys, L., Maira, S.M.et al. (2009) Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Mol. Cancer Ther. 8, 742&#x2013;753 10.1158/1535-7163.MCT-08-0668</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-08-0668</ArticleId><ArticleId IdType="pmc">PMC3440776</ArticleId><ArticleId IdType="pubmed">19372546</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J. and Cantley, L.C. (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway. Mol. Cell 10, 151&#x2013;162 10.1016/S1097-2765(02)00568-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00568-3</ArticleId><ArticleId IdType="pubmed">12150915</ArticleId></ArticleIdList></Reference><Reference><Citation>Castel, P., Ellis, H., Bago, R., Toska, E., Razavi, P., Carmona, F.J.et al. (2016) PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3K&#x3b1; inhibition. Cancer Cell 30, 229&#x2013;242 10.1016/j.ccell.2016.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2016.06.004</ArticleId><ArticleId IdType="pmc">PMC4982440</ArticleId><ArticleId IdType="pubmed">27451907</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan, J., Chitta, R.K., Harwood, F.C. and Grosveld, G.C. (2019) Phosphorylation of TSC2 by PKC-&#x3b4; reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity. Mol. Cell. Biochem. 456, 123&#x2013;134 10.1007/s11010-019-03498-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-019-03498-8</ArticleId><ArticleId IdType="pubmed">30684133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee, A.R., Anjum, R. and Blenis, J. (2003) Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J. Biol. Chem. 278, 37288&#x2013;37296 10.1074/jbc.M303257200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303257200</ArticleId><ArticleId IdType="pubmed">12867426</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed, S.T., Majeed, R., Malik, A.A. and Andrabi, K.I. (2023) MTORC2 is a physiological hydrophobic motif kinase of S6 Kinase 1. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119449 10.1016/j.bbamcr.2023.119449</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2023.119449</ArticleId><ArticleId IdType="pubmed">36858209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalski, J.R., Bhaduri, A., Zehnder, A.M., Neela, P.H., Che, Y., Wozniak, G.G.et al. (2019) The functional proximal proteome of oncogenic Ras includes mTORC2. Mol. Cell 73, 830&#x2013;844.e12 10.1016/j.molcel.2018.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.12.001</ArticleId><ArticleId IdType="pmc">PMC6386588</ArticleId><ArticleId IdType="pubmed">30639242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebali, A., Battistella, M., Lebbe, C. and Dumaz, N. (2021) RICTOR affects melanoma tumorigenesis and its resistance to targeted therapy. Biomedicines 9, 1498 10.3390/biomedicines9101498</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101498</ArticleId><ArticleId IdType="pmc">PMC8533235</ArticleId><ArticleId IdType="pubmed">34680615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone, M.U., Miyan, J., Asif, M., Malik, S.A., Dubey, P., Singh, V.et al. (2019) Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling. BMC Cancer 19, 1236 10.1186/s12885-019-6422-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-019-6422-6</ArticleId><ArticleId IdType="pmc">PMC6921532</ArticleId><ArticleId IdType="pubmed">31856761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalski, J.R., Shanderson, R.L. and Khavari, P.A. (2019) Ras functional proximity proteomics establishes mTORC2 as new direct ras effector. Oncotarget 10, 5126&#x2013;5135 10.18632/oncotarget.27025</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.27025</ArticleId><ArticleId IdType="pmc">PMC6718260</ArticleId><ArticleId IdType="pubmed">31497244</ArticleId></ArticleIdList></Reference><Reference><Citation>Saci, A., Cantley, L.C. and Carpenter, C.L. (2011) Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol. Cell 42, 50&#x2013;61 10.1016/j.molcel.2011.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.03.017</ArticleId><ArticleId IdType="pmc">PMC3750737</ArticleId><ArticleId IdType="pubmed">21474067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Negrete, I., Carretero-Ortega, J., Rosenfeldt, H., Hernandez-Garcia, R., Calderon-Salinas, J.V., Reyes-Cruz, G.et al. (2007) P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J. Biol. Chem. 282, 23708&#x2013;23715 10.1074/jbc.M703771200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703771200</ArticleId><ArticleId IdType="pubmed">17565979</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison Joly, M., Hicks, D.J., Jones, B., Sanchez, V., Estrada, M.V., Young, C.et al. (2016) Rictor/mTORC2 drives progression and therapeutic resistance of HER2-amplified breast cancers. Cancer Res. 76, 4752&#x2013;4764 10.1158/0008-5472.CAN-15-3393</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-3393</ArticleId><ArticleId IdType="pmc">PMC5758362</ArticleId><ArticleId IdType="pubmed">27197158</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna, N., Fang, Y., Yoon, M.S. and Chen, J. (2013) XPLN is an endogenous inhibitor of mTORC2. Proc. Natl Acad. Sci. U.S.A. 110, 15979&#x2013;15984 10.1073/pnas.1310434110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1310434110</ArticleId><ArticleId IdType="pmc">PMC3791717</ArticleId><ArticleId IdType="pubmed">24043828</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, W. and Andres, D.A. (2014) mTORC2 is required for Rit-mediated oxidative stress resistance. PLoS One 9, e115602 10.1371/journal.pone.0115602</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115602</ArticleId><ArticleId IdType="pmc">PMC4274107</ArticleId><ArticleId IdType="pubmed">25531880</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciano, A.K., Korobkina, E.D., Lyons, S.P., Haley, J.A., Fluharty, S.M., Jung, S.M.et al. (2022) Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1. J. Biol. Chem. 298, 102379 10.1016/j.jbc.2022.102379</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102379</ArticleId><ArticleId IdType="pmc">PMC9513271</ArticleId><ArticleId IdType="pubmed">35973513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson, M.G., Pino, T.S., Tournier, S., Buck, V., Martin, H., Christiansen, J.et al. (1999) Sin1: an evolutionarily conserved component of the eukaryotic SAPK pathway. EMBO J. 18, 4210&#x2013;4221 10.1093/emboj/18.15.4210</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.15.4210</ArticleId><ArticleId IdType="pmc">PMC1171497</ArticleId><ArticleId IdType="pubmed">10428959</ArticleId></ArticleIdList></Reference><Reference><Citation>Leskoske, K.L., Roelants, F.M., Emmerstorfer-Augustin, A., Augustin, C.M., Si, E.P., Hill, J.M.et al. (2018) Phosphorylation by the stress-activated MAPK Slt2 down-regulates the yeast TOR complex 2. Genes Dev. 32, 1576&#x2013;1590 10.1101/gad.318709.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.318709.118</ArticleId><ArticleId IdType="pmc">PMC6295167</ArticleId><ArticleId IdType="pubmed">30478248</ArticleId></ArticleIdList></Reference><Reference><Citation>Morigasaki, S., Chin, L.C., Hatano, T., Emori, M., Iwamoto, M., Tatebe, H.et al.  (2019) Modulation of TOR complex 2 signaling by the stress-activated MAPK pathway in fission yeast. J. Cell Sci.
132 PubMed https://pubmed.ncbi.nlm.nih.gov/31477575/</Citation><ArticleIdList><ArticleId IdType="pubmed">31477575</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman, M., Chen, W. and Cobb, M.H. (2007) Differential regulation and properties of MAPKs. Oncogene 26, 3100&#x2013;3112 10.1038/sj.onc.1210392</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1210392</ArticleId><ArticleId IdType="pubmed">17496909</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder, W., Bushell, G. and Sculley, T. (2005) The human stress-activated protein kinase-interacting 1 gene encodes JNK-binding proteins. Cell Signal. 17, 761&#x2013;767 10.1016/j.cellsig.2004.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2004.10.015</ArticleId><ArticleId IdType="pubmed">15722200</ArticleId></ArticleIdList></Reference><Reference><Citation>Colicelli, J., Nicolette, C., Birchmeier, C., Rodgers, L., Riggs, M. and Wigler, M. (1991) Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. U.S.A. 88, 2913&#x2013;2917 10.1073/pnas.88.7.2913</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.7.2913</ArticleId><ArticleId IdType="pmc">PMC51350</ArticleId><ArticleId IdType="pubmed">1849280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S., Parent, C.A., Insall, R. and Firtel, R.A. (1999) A novel Ras-interacting protein required for chemotaxis and cyclic adenosine monophosphate signal relay in Dictyostelium. Mol. Biol. Cell 10, 2829&#x2013;2845 10.1091/mbc.10.9.2829</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.10.9.2829</ArticleId><ArticleId IdType="pmc">PMC25521</ArticleId><ArticleId IdType="pubmed">10473630</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, P.C., Rajput, S., Zhao, X., Patel, C., Albaciete, D., Oh, W.J.et al. (2020) mTORC2 is involved in the induction of RSK phosphorylation by serum or nutrient starvation. Cells 9, 1567 10.3390/cells9071567</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071567</ArticleId><ArticleId IdType="pmc">PMC7408474</ArticleId><ArticleId IdType="pubmed">32605013</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire, V.A., Gray, A., Monk, C.E., Santos, S.G., Lee, K., Aubareda, A.et al. (2013) Cross talk between the Akt and p38&#x3b1; pathways in macrophages downstream of Toll-like receptor signaling. Mol. Cell. Biol. 33, 4152&#x2013;4165 10.1128/MCB.01691-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01691-12</ArticleId><ArticleId IdType="pmc">PMC3811899</ArticleId><ArticleId IdType="pubmed">23979601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamming, D.W., Demirkan, G., Boylan, J.M., Mihaylova, M.M., Peng, T., Ferreira, J.et al. (2014) Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). FASEB J. 28, 300&#x2013;315 10.1096/fj.13-237743</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-237743</ArticleId><ArticleId IdType="pmc">PMC3868844</ArticleId><ArticleId IdType="pubmed">24072782</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavides-Serrato, A., Anderson, L., Holmes, B., Cloninger, C., Artinian, N., Bashir, T.et al. (2014) mTORC2 modulates feedback regulation of p38 MAPK activity via DUSP10/MKP5 to confer differential responses to PP242 in glioblastoma. Genes Cancer 5, 393&#x2013;406 10.18632/genesandcancer.41</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/genesandcancer.41</ArticleId><ArticleId IdType="pmc">PMC4279437</ArticleId><ArticleId IdType="pubmed">25568665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun, J., Kwon, T., Kim, D.J., Park, I., Chung, G., Lee, E.J.et al. (2003) Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoid-induced kinase 1. J. Biochem. 133, 103&#x2013;108 10.1093/jb/mvg010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvg010</ArticleId><ArticleId IdType="pubmed">12761204</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Q., Song, X.M., Ji, Y.Y., Jiang, H. and Xu, L.G. (2013) The dual mTORC1 and mTORC2 inhibitor AZD8055 inhibits head and neck squamous cell carcinoma cell growth in vivo and in vitro. Biochem. Biophys. Res. Commun. 440, 701&#x2013;706 10.1016/j.bbrc.2013.09.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.09.130</ArticleId><ArticleId IdType="pubmed">24103749</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, N.M., Mazzoni, S.M., Vittal, R., Fingar, D.C. and Lama, V.N. (2018) c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis. J. Biol. Chem. 293, 17229&#x2013;17239 10.1074/jbc.RA118.003926</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003926</ArticleId><ArticleId IdType="pmc">PMC6222104</ArticleId><ArticleId IdType="pubmed">30217824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W., Shen, T., Dong, B., Creighton, C.J., Meng, Y., Zhou, W.et al. (2019) MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling. J. Clin. Invest. 129, 1015&#x2013;1029 10.1172/JCI97712</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI97712</ArticleId><ArticleId IdType="pmc">PMC6391107</ArticleId><ArticleId IdType="pubmed">30688659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilman, D. and Gat, U. (2011) The evolutionary history of YAP and the hippo/YAP pathway. Mol. Biol. Evol. 28, 2403&#x2013;2417 10.1093/molbev/msr065</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msr065</ArticleId><ArticleId IdType="pubmed">21415026</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin, J.M., Wu, Z. and Guan, K.L. (2023) Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat. Rev. Cancer 23, 512&#x2013;525 10.1038/s41568-023-00579-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-023-00579-1</ArticleId><ArticleId IdType="pubmed">37308716</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciarretta, S., Zhai, P., Maejima, Y., Del Re, D.P., Nagarajan, N., Yee, D.et al. (2015) mTORC2 regulates cardiac response to stress by inhibiting MST1. Cell Rep. 11, 125&#x2013;136 10.1016/j.celrep.2015.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.03.010</ArticleId><ArticleId IdType="pmc">PMC4417361</ArticleId><ArticleId IdType="pubmed">25843706</ArticleId></ArticleIdList></Reference><Reference><Citation>Raynor, J.L., Liu, C., Dhungana, Y., Guy, C., Chapman, N.M., Shi, H.et al. (2020) Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions. J. Exp. Med. 217, e20191157 10.1084/jem.20191157</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191157</ArticleId><ArticleId IdType="pmc">PMC7971129</ArticleId><ArticleId IdType="pubmed">32289155</ArticleId></ArticleIdList></Reference><Reference><Citation>Artinian, N., Cloninger, C., Holmes, B., Benavides-Serrato, A., Bashir, T. and Gera, J. (2015) Phosphorylation of the hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness. J. Biol. Chem. 290, 19387&#x2013;19401 10.1074/jbc.M115.656587</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.656587</ArticleId><ArticleId IdType="pmc">PMC4528104</ArticleId><ArticleId IdType="pubmed">25998128</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, B., Benavides-Serrato, A., Saunders, J.T., Kumar, S., Nishimura, R.N. and Gera, J. (2021) mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics. Neoplasia 23, 951&#x2013;965 10.1016/j.neo.2021.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2021.07.005</ArticleId><ArticleId IdType="pmc">PMC8347669</ArticleId><ArticleId IdType="pubmed">34343821</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu, S., Totty, N.F., Irwin, M.S., Sudol, M. and Downward, J. (2003) Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11&#x2013;23 10.1016/S1097-2765(02)00776-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00776-1</ArticleId><ArticleId IdType="pubmed">12535517</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo, G., Kim, T., Chung, C., Hwang, D.S. and Lim, D.S. (2017) The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3&#x3b2;-mediated TAZ destabilization. Biochem. Biophys. Res. Commun. 490, 650&#x2013;656 10.1016/j.bbrc.2017.06.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.06.092</ArticleId><ArticleId IdType="pubmed">28634071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui, Y., Li, J., Lu, Q., Feng, Y., Wang, M., He, W.et al. (2018) Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis. J. Biol. Chem. 293, 16364&#x2013;16375 10.1074/jbc.RA118.004073</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004073</ArticleId><ArticleId IdType="pmc">PMC6200934</ArticleId><ArticleId IdType="pubmed">30154246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumaneng, K., Schlegelmilch, K., Russell, R.C., Yimlamai, D., Basnet, H., Mahadevan, N.et al. (2012) YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat. Cell Biol. 14, 1322&#x2013;1329 10.1038/ncb2615</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2615</ArticleId><ArticleId IdType="pmc">PMC4019071</ArticleId><ArticleId IdType="pubmed">23143395</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, M., Yan, G., Wang, N., Daliah, G., Edick, A.M., Poulet, S.et al. (2021) In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nat. Commun. 12, 3055 10.1038/s41467-021-23316-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23316-4</ArticleId><ArticleId IdType="pmc">PMC8144221</ArticleId><ArticleId IdType="pubmed">34031411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, T., Nakashima, A., Guo, L., Coffman, K. and Tamanoi, F. (2010) Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer. Oncogene 29, 2746&#x2013;2752 10.1038/onc.2010.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2010.28</ArticleId><ArticleId IdType="pmc">PMC2953941</ArticleId><ArticleId IdType="pubmed">20190810</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabiner, B.C., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S.et al. (2014) A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 4, 554&#x2013;563 10.1158/2159-8290.CD-13-0929</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-13-0929</ArticleId><ArticleId IdType="pmc">PMC4012430</ArticleId><ArticleId IdType="pubmed">24631838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagle, N., Grabiner, B.C., Van Allen, E.M., Hodis, E., Jacobus, S., Supko, J.G.et al. (2014) Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. Cancer Discov. 4, 546&#x2013;553 10.1158/2159-8290.CD-13-0353</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-13-0353</ArticleId><ArticleId IdType="pmc">PMC4122326</ArticleId><ArticleId IdType="pubmed">24625776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi, H., Kawazu, M., Yasuda, T., Soda, M., Ueno, T., Kojima, S.et al. (2015) Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer. Cancer Sci. 106, 1687&#x2013;1692 10.1111/cas.12828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.12828</ArticleId><ArticleId IdType="pmc">PMC4714661</ArticleId><ArticleId IdType="pubmed">26432419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, Y., Si, L., Li, Y., Wu, X., Xu, X., Dai, J.et al. (2016) Analysis of mTOR gene aberrations in melanoma patients and evaluation of their sensitivity to PI3K&#x2013;AKT&#x2013;mTOR pathway inhibitors. Clin. Cancer Res. 22, 1018&#x2013;1027 10.1158/1078-0432.CCR-15-1110</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-15-1110</ArticleId><ArticleId IdType="pubmed">26490311</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan, A.K., Liu, R. and Xing, M. (2019) Identification and characterization of two novel oncogenic mTOR mutations. Oncogene 38, 5211&#x2013;5226 10.1038/s41388-019-0787-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-019-0787-5</ArticleId><ArticleId IdType="pmc">PMC6597304</ArticleId><ArticleId IdType="pubmed">30918329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, H., Zou, Y., Ross, J.S., Wang, K., Liu, X., Halmos, B.et al. (2015)RICTOR amplification defines a novel subset of patients with lung cancer who may benefit from treatment with mTORC1/2 inhibitors. Cancer Discov. 5, 1262&#x2013;1270 10.1158/2159-8290.CD-14-0971</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-14-0971</ArticleId><ArticleId IdType="pmc">PMC4670806</ArticleId><ArticleId IdType="pubmed">26370156</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenzle, J., Akasaka, H., Joechle, K., Reichardt, W., Venkatasamy, A., Hoeppner, J.et al. (2021) Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma. Int. J. Mol. Sci. 22, 30 10.3390/ijms22010030</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010030</ArticleId><ArticleId IdType="pmc">PMC7792954</ArticleId><ArticleId IdType="pubmed">33375117</ArticleId></ArticleIdList></Reference><Reference><Citation>Werfel, T.A., Wang, S., Jackson, M.A., Kavanaugh, T.E., Joly, M.M., Lee, L.H.et al. (2018) Selective mTORC2 inhibitor therapeutically blocks breast cancer cell growth and survival. Cancer Res. 78, 1845&#x2013;1858 10.1158/0008-5472.CAN-17-2388</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-2388</ArticleId><ArticleId IdType="pmc">PMC5882532</ArticleId><ArticleId IdType="pubmed">29358172</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar, R., Garcia-Carbonero, R., Libutti, S.K., Hendifar, A.E., Custodio, A., Guimbaud, R.et al. (2018) Phase II study of BEZ235 versus everolimus in patients with mammalian target of rapamycin inhibitor-na&#xef;ve advanced pancreatic neuroendocrine tumors. Oncologist 23, 766-e90 10.1634/theoncologist.2017-0144</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2017-0144</ArticleId><ArticleId IdType="pmc">PMC6058330</ArticleId><ArticleId IdType="pubmed">29242283</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlo, M.I., Molina, A.M., Lakhman, Y., Patil, S., Woo, K., DeLuca, J.et al. (2016) A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma. Oncologist 21, 787&#x2013;788 10.1634/theoncologist.2016-0145</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2016-0145</ArticleId><ArticleId IdType="pmc">PMC4943396</ArticleId><ArticleId IdType="pubmed">27286790</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajdev, L., Lee, J.W., Libutti, S.K., Benson, A.B., Fisher, Jr, G.A., Kunz, P.L.et al. . (2022) A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161. Invest. New Drugs 40, 1306&#x2013;1314. 10.1007/s10637-022-01311-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-022-01311-w</ArticleId><ArticleId IdType="pmc">PMC9795724</ArticleId><ArticleId IdType="pubmed">36264382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mita, M., Fu, S., Piha-Paul, S.A., Janku, F., Mita, A., Natale, R.et al. (2017) Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors. Invest. New Drugs 35, 616&#x2013;626 10.1007/s10637-017-0442-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-017-0442-3</ArticleId><ArticleId IdType="pmc">PMC5935457</ArticleId><ArticleId IdType="pubmed">28194539</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram, A.M., Gandhi, L., Mita, M.M., Damstrup, L., Campana, F., Hidalgo, M.et al. (2018) A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours. Br. J. Cancer 119, 1471&#x2013;1476 10.1038/s41416-018-0322-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-018-0322-4</ArticleId><ArticleId IdType="pmc">PMC6288157</ArticleId><ArticleId IdType="pubmed">30425349</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiff, D., Jaeckle, K.A., Anderson, S.K., Galanis, E., Giannini, C., Buckner, J.C.et al. (2018) Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. Cancer 124, 1455&#x2013;1463 10.1002/cncr.31219</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.31219</ArticleId><ArticleId IdType="pmc">PMC5867230</ArticleId><ArticleId IdType="pubmed">29313954</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing, Y., Lin, N.U., Maurer, M.A., Chen, H., Mahvash, A., Sahin, A.et al. (2019) Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. Breast Cancer Res. 21, 78 10.1186/s13058-019-1154-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13058-019-1154-8</ArticleId><ArticleId IdType="pmc">PMC6612080</ArticleId><ArticleId IdType="pubmed">31277699</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell, S.J., Casbard, A., Carucci, M., Ingarfield, K., Butler, R., Morgan, S.et al. (2022) Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. Lancet Oncol. 23, 851&#x2013;864 10.1016/S1470-2045(22)00284-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(22)00284-4</ArticleId><ArticleId IdType="pmc">PMC9630162</ArticleId><ArticleId IdType="pubmed">35671774</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha Bhattarai, T., Shamu, T., Gorelick, A.N., Chang, M.T., Chakravarty, D., Gavrila, E.I.et al. (2022) AKT mutant allele-specific activation dictates pharmacologic sensitivities. Nat. Commun. 13, 2111 10.1038/s41467-022-29638-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29638-1</ArticleId><ArticleId IdType="pmc">PMC9018718</ArticleId><ArticleId IdType="pubmed">35440569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano, T., Inokuchi, J., Eto, M., Murata, M. and Kang, J.H. (2021) Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials. Pharmaceutics
13 PubMed https://pubmed.ncbi.nlm.nih.gov/34834162/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621927</ArticleId><ArticleId IdType="pubmed">34834162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicenas, J., Meskinyte-Kausiliene, E., Jukna, V., Rimkus, A., Simkus, J. and Soderholm, D. (2022) SGK1 in cancer: biomarker and drug target. Cancers 14, 2385 10.3390/cancers14102385</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14102385</ArticleId><ArticleId IdType="pmc">PMC9139822</ArticleId><ArticleId IdType="pubmed">35625991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, G., Yan, Y., Xu, N., Hui, Y. and Yin, D. (2019) Upregulation of microRNA-424 relieved diabetic nephropathy by targeting Rictor through mTOR Complex2/Protein Kinase B signaling. J. Cell. Physiol. 234, 11646&#x2013;11653 10.1002/jcp.27822</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27822</ArticleId><ArticleId IdType="pubmed">30637733</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentel, B., Escamilla, C.O. and Tsai, P.T. (2019) Therapeutic targeting of mTORC2 in mTORopathies. Neuron 104, 1032&#x2013;1033 10.1016/j.neuron.2019.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.11.026</ArticleId><ArticleId IdType="pubmed">31951535</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney, S.J., Narayan, S., Molz, L., Berstler, L.A., Kang, S.A., Vlasuk, G.P.et al. (2018) A small molecule inhibitor of Rheb selectively targets mTORC1 signaling. Nat. Commun. 9, 548 10.1038/s41467-018-03035-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03035-z</ArticleId><ArticleId IdType="pmc">PMC5803267</ArticleId><ArticleId IdType="pubmed">29416044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce, L.R., Alton, G.R., Richter, D.T., Kath, J.C., Lingardo, L., Chapman, J.et al. (2010) Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem. J. 431, 245&#x2013;255 10.1042/BJ20101024</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20101024</ArticleId><ArticleId IdType="pubmed">20704563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, J., Liu, Y., Tran, J., O'Neal, P., Baudry, M. and Bi, X. (2016) mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice. Cell. Mol. Life Sci. 73, 4303&#x2013;4314 10.1007/s00018-016-2269-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2269-z</ArticleId><ArticleId IdType="pmc">PMC5056144</ArticleId><ArticleId IdType="pubmed">27173058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen, Y.T., Zhang, J.R., Kapupara, K. and Tsai, R.K. (2019) mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury. Exp. Mol. Med. 51, 1&#x2013;11 10.1038/s12276-019-0298-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0298-z</ArticleId><ArticleId IdType="pmc">PMC6802655</ArticleId><ArticleId IdType="pubmed">31409770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.Y., Liu, M.Y., Liu, Z., Zhao, J.K., Zhao, Y.G., He, L.et al. (2019) GPR30-mediated estrogenic regulation of actin polymerization and spatial memory involves SRC-1 and PI3K-mTORC2 in the hippocampus of female mice. CNS Neurosci. Ther. 25, 714&#x2013;733 10.1111/cns.13108</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13108</ArticleId><ArticleId IdType="pmc">PMC6515707</ArticleId><ArticleId IdType="pubmed">30714337</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng, Y., Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J.et al. (2022) Scavenging reactive oxygen species decreases amyloid-&#x3b2; levels via activation of PI3K/Akt/GLUT1 pathway in N2a/APP695swe cells. J. Alzheimers Dis. 90, 185&#x2013;198 10.3233/JAD-220610</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220610</ArticleId><ArticleId IdType="pubmed">36093707</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo, H., Mondal, S., Tan, D., Nagata, E., Takizawa, S., Sharma, A.K.et al. (2012) Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc. Natl Acad. Sci. U.S.A. 109, 10581&#x2013;10586 10.1073/pnas.1202810109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1202810109</ArticleId><ArticleId IdType="pmc">PMC3387065</ArticleId><ArticleId IdType="pubmed">22689977</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss, H.R., Chi, O.Z., Kiss, G.K., Liu, X., Damito, S. and Jacinto, E. (2018) Akt activation improves microregional oxygen supply/consumption balance after cerebral ischemia-reperfusion. Brain Res. 1683, 48&#x2013;54 10.1016/j.brainres.2018.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.019</ArticleId><ArticleId IdType="pubmed">29371097</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing, Z.T., Liu, W., Xue, C.R., Wu, S.X., Chen, W.N., Lin, X.J.et al. (2019) AKT activator SC79 protects hepatocytes from TNF-&#x3b1;-mediated apoptosis and alleviates d-Gal/LPS-induced liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 316, G387&#x2013;G396 10.1152/ajpgi.00350.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00350.2018</ArticleId><ArticleId IdType="pubmed">30629471</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>